Skip to main content
PLOS Computational Biology logoLink to PLOS Computational Biology
. 2023 Jan 13;19(1):e1010841. doi: 10.1371/journal.pcbi.1010841

Conformational dynamics and putative substrate extrusion pathways of the N-glycosylated outer membrane factor CmeC from Campylobacter jejuni

Kahlan E Newman 1, Syma Khalid 1,2,*
Editor: Guanghong Wei3
PMCID: PMC9879487  PMID: 36638139

Abstract

The outer membrane factor CmeC of the efflux machinery CmeABC plays an important role in conferring antibiotic and bile resistance to Campylobacter jejuni. Curiously, the protein is N-glycosylated, with the glycans playing a key role in the effective function of this system. In this work we have employed atomistic equilibrium molecular dynamics simulations of CmeC in a representative model of the C. jejuni outer membrane to characterise the dynamics of the protein and its associated glycans. We show that the glycans are more conformationally labile than had previously been thought. The extracellular loops of CmeC visit the open and closed states freely suggesting the absence of a gating mechanism on this side, while the narrow periplasmic entrance remains tightly closed, regulated via coordination to solvated cations. We identify several cation binding sites on the interior surface of the protein. Additionally, we used steered molecular dynamics simulations to elucidate translocation pathways for a bile acid and a macrolide antibiotic. These, and additional equilibrium simulations suggest that the anionic bile acid utilises multivalent cations to climb the ladder of acidic residues that line the interior surface of the protein.

Author summary

Campylobacter jejuni is a Gram-negative bacterium that is a major cause of gastroenteritis. Infection is also associated with the development of some auto-immune conditions. Therefore, it is of key biomedical importance.

Bacterial efflux pumps extrude waste and harmful chemicals, including antibiotics from inside the cell to the extracellular environment, thus providing an impediment to antibacterial treatments. The major efflux system of C. jejuni is the cell envelope spanning CmeABC protein complex. The outer membrane factor CmeC plays an important role in conferring antibiotic and bile resistance to C. jejuni. We have used molecular dynamics simulations of CmeC to characterise the pathways via which a bile acid and an antibiotic move through this glycosylated protein. We identify several cation-binding sites within the lumen of the protein and show that the anionic bile acid utilises multivalent cations to climb the ladder of acidic residues that line the interior surface of the protein.

Introduction

The Gram-negative bacterium Campylobacter jejuni is considered a leading cause of gastroenteritis, infecting an estimated 400 million people annually [1]. This thermophilic, microaerophilic enteropathogen is an asymptomatic commensal organism in avian species [25]. As such, up to 90% of retailed chicken carcasses are contaminated with C. jejuni [6,7] and the leading cause of human infection in developed countries is through inappropriate handling or undercooking of poultry products [2,5,812]. Human disease is most commonly acute but self-limiting, presenting as a fever, abdominal cramping and diarrhoea [13,14]. However, infection is also associated with the development of debilitating auto-immune conditions such as Miller-Fisher syndrome and Guillain-Barré syndrome [1520].

C. jejuni displays resistance to a variety of antibiotic classes through several resistance mechanisms [21,22]. Almost invariably, the main multi-drug efflux system in this bacterium, CmeABC, works synergistically with other mechanisms (such as decreasing outer membrane permeability) [21] to confer a higher level of both intrinsic and acquired resistance to these antimicrobials by reducing their intracellular concentration. In severe cases of bacterial diarrhoea, antibiotics may be prescribed. The macrolide antibiotic erythromycin is used if campylobacteriosis is suspected [23] but fluoroquinolones are commonly used if the infection source is unclear; CmeABC has been shown to contribute resistance to both macrolides and fluoroquinolones, with resistance to the latter class now widespread due to its indiscriminate use in poultry farming and clinical environments [2426]. CmeABC has also been shown to confer bile resistance [27] which is essential for the survival of this bacterium in its main reservoir of poultry intestinal tracts [2]. This efflux assembly comprises three proteins: the resistance-nodulation-division (RND) inner membrane transporter, CmeB; the periplasmic adaptor protein (PAP), CmeA; and the outer membrane factor (OMF), CmeC.

The OMF of this machinery is similar in structure to its homologues TolC and CusC (Escherichia coli) [28,29], MtrE (Neisseria gonorrhoeae) [30], and OprM (Pseudomonas aeruginosa) [31]. CmeC is a ‘cannon-shaped’ homotrimer that forms a 130 Å channel through which substrates can be extruded into the extracellular environment [32]. Three key subdomains of the protein delimit this channel: the β-barrel; the α-barrel; and the coiled coil domains (Fig 1A). The β-barrel is ~30 Å tall and spans most of the outer membrane, while the α-barrel and coiled coil domains extend ~100 Å into the periplasmic space where this protein couples to CmeA and presumably the peptidoglycan cell wall. Like TolC, OprM, and CusC, the interior surface of CmeC is highly electronegative with aspartate and glutamate residues constituting a considerable proportion of the lining residues [32] (Fig 1B). Each member of the CmeABC assembly is N-glycosylated by the attachment of the following heptasaccharide [33] (S1 Fig):

Fig 1. Protein and substrate structures.

Fig 1

(A) CmeC embedded in a model C. jejuni outer membrane. CmeC shown in orange New Cartoon representation, with N-terminal lipidation shown in orange van der Waals (VDW); phospholipids shown as cyan surface; Lipid A moieties of LOS shown as a dark blue surface; and LOS oligosaccharides and N-glycans shown as a purple surface. The β-barrel and top of the α-barrel are embedded in the hydrophobic membrane core. (B) Cutaway of the x-ray crystallographic structure of CmeC (grey New Cartoon), with acidic and basic residues that line the central channel shown in red and blue VDW representation respectively. Residues identified as constrictions in the X-ray crystal structure (R104 and E416) labelled. (C) Structure of the macrolide antibiotic erythromycin. (D) Structure of the bile acid chenodeoxycholic acid (CDCA). The proton highlighted by the red box is removed in solution to yield a carboxylate group.

GalNAc-α1,4-GalNAc-α1,4-[Glc-β-1,3]GalNAc-α1,4-GalNAc-α1,4-GalNAc-α1,3-diNAcBac-β1 where diNAcBac is N’,N’-diacetylbacillosamine [2,4-diacetamido-2,4,6 trideoxyglucopyranose]; GalNAc is N-acetylgalactosamine; and Glc is glucose. Removal of the N-glycosylation pathway results in diminished activity of this efflux machinery [34], as well as pleiotropic effects such as reduced motility [35] and virulence [36]. CmeC has two experimentally validated glycosylation sites: 11EANYS15 and 28ETNSS32 (residue numbers are after signal peptide cleavage).

Previous in silico and mutational studies aiming to elucidate OMF dynamics have primarily focused on TolC from the archetypal Gram-negative bacterium E. coli [3744], though OprM from P. aeruginosa, and MtrE from N. gonorrhoeae have also been simulated [4547]. These studies have shown several common features of OMFs. These proteins display two constriction regions: one at the periplasmic entrance and one at the extracellular exit. Contrary to initial molecular dynamics (MD) studies [38] OMFs are putatively gated at the periplasmic entrance only [41,43,45]. The extracellular loops that define the extracellular constriction have been shown to visit open and closed states freely, while the periplasmic entrance remains locked closed by extensive inter- and intraprotomer hydrogen bonding and salt bridges, with TolC and OprM also showing interactions with cations [41,4345]. The coiled-coil domain of these proteins opens in an ‘iris-like’ fashion at the cost of disrupting the circular hydrogen bonding and salt bridge networks in this region; this occurs spontaneously on coupling to the PAP, but requires energetic input for the isolated OMF to prevent the uncontrolled diffusion of solutes [39,43,44].

Analogous simulation studies of the OMF of CmeABC, CmeC, are absent in the literature and to the best of our knowledge the components of the N-glycosylated CmeABC system have not previously been simulated. Here we present equilibrium molecular dynamics simulations of the OMF CmeC in a biologically relevant C. jejuni outer membrane model. The results of these simulations suggest that N-glycans are more conformationally labile than previously thought, and that CmeC behaves similarly to other OMFs with cation-dependent gating at the periplasmic entrance and no gating mechanism at the extracellular exit. In addition, we present steered molecular dynamics simulations in which two known substrates of this efflux machinery, the macrolide antibiotic erythromycin and the bile acid chenodeoxycholic acid (CDCA) (Fig 1C and 1D), are pulled through this outer membrane channel. We investigate the orientation preference of these molecules within the channel, and propose a mechanism of translocation for the anionic CDCA substrate.

Results and discussion

CmeC stability within the membrane

Previous simulation studies of OMFs TolC and OprM used simplified membrane models [37,38,4042,45]. While useful data may still be extracted from these simulations, phospholipid bilayers are not fully representative of the physicochemical properties of Gram-negative outer membranes; experimental and computational studies have shown components of the outer membrane, such as LPS (lipopolysaccharide), to affect the structure and function of outer membrane proteins [4852]. Recent in silico studies of systems containing efflux machinery have used more complex outer membrane models, though the dynamics of the OMF of these systems have not been the main focus of the studies [46,53]. In this work, the N-glycosylated CmeC trimer was inserted into a biologically-relevant C. jejuni outer membrane model containing ganglioside-mimicry LOS (lipooligosaccharide) in the outer leaflet and a mixture of POPE and POPG (18:1:1 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine and 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol, respectively) in the periplasmic leaflet [54,55]. We note that while this membrane model is closer to being biologically accurate than a simple, symmetrical phospholipid bilayer, lysophospholipids, which have recently been discovered to constitute a large proportion of the C. jejuni lipodome [56], are not included.

Three x 500 ns equilibrium simulations were performed to assess the stability of this system. Dimensions of the simulation box plateaued after ~300 ns in all three replicates (S2 Fig). The root-mean-square deviation (RMSD) of the protein backbone continues to increase across the simulation in all cases (S3 Fig) indicating that CmeC is not yet fully equilibrated. This is to be expected, given the size and complexity of the system and the starting conformation being close to the crystal structure. One simulation was extended to 1,250 ns; the backbone RMSD continued to increase across this longer simulation (S3 Fig). The continued rise in RMSD is primarily driven by the β-barrel; this is the domain in which the crystallisation and simulation environments are most different, and full equilibration in this region will be slow due to the use of slow-moving LOS [57] in the outer leaflet. The 3 x 500ns simulation trajectories were concatenated and principal component analysis (PCA) was undertaken. Each of the trajectories was projected along the first three eigenvectors (which cumulatively accounted for 32.3% of the variance, S1 Table). Each trajectory sampled different subspaces unique from the crystal structure (Fig 2A), therefore in combination these replicates likely give better coverage of the conformational landscape than we would expect from a single trajectory of the same length.

Fig 2. Analysis of the protein dynamics.

Fig 2

(A) Projections of the backbone trajectories of each replicate along the first three eigenvectors. Each replicate samples a different conformational space, each unique from the crystal structure. (B) Root-mean-square fluctuation (RMSF) by residue (calculated from the protein backbone, averaged across the three protomers in each of the three replicates). Average trace shown as a solid blue line, associated standard deviation shown in pale blue. Background coloured by secondary structure: pink = α-helices, green = β-sheets, white = no formally defined secondary structure.

Secondary structure analysis (SSA) of the protein shows CmeC to be stable in the membrane, with no substantial changes in secondary structure over the course of the simulations (S4 Fig). The root-mean-square fluctuation (RMSF) is consistent with the SSA and with the topology defined by Su et al. from the crystal structure [32]; the greatest fluctuations are observed for residues in unstructured regions such as the first extracellular loop (residues 96–108, henceforth referred to as L1), N- and C-termini, and between α-helices at the periplasmic end of the protein (e.g. residues 195–200) (Fig 2B). The N-terminus is lipidated, anchored to the inner leaflet of the membrane, hence it displays lower RMSF values than the C-terminus. Interestingly, the second extracellular loop (residues 309–323, henceforth referred to as L2) shows substantially less fluctuation than the first loop. The L1 loops are directed upwards, normal to the membrane or tilted towards the centre of the β-barrel, whereas the L2 loops are parallel to the membrane, projecting out into the LOS headgroups (Fig 3A and 3B).

Fig 3.

Fig 3

(A) Side-view of the CmeC β-barrel in the outer membrane model; (B) top-down view of the CmeC β-barrel. β-sheets and top of the α-barrel in orange, residues 96–108 (extracellular loop 1, L1) in blue, residues 309–323 (extracellular loop 2, L2) in green. (A & B) show L1 loops to project upwards and into the center of the β-barrel, but L2 loops to project out radially into the outer leaflet of the outer membrane. (C) Salt bridge formed between K322 residue in L2 and the phosphates of neighbouring lipid A moieties. (D) Acidic residues D312 and D314 can simultaneously coordinate calcium ions (pale green) from amongst the LOS headgroups, and hydrogen bond with KDO sugar moieties in neighbouring LOS molecules. The hydrophobic side chain of L313 is embedded amongst the lipid tails within the membrane core, anchoring L2 to the outer leaflet.

Hydrogen bond analysis (cut-offs of 3 Å and 20°) reveals multiple high-occupancy interactions between LOS and residues within L2. The basic side chains of residues K322 and K318 interact extensively with the phosphate groups of the LOS molecules (Fig 3C): hydrogen bonds between the lysine side chains and LOS phosphates were observed in >80% of trajectory frames. Acidic residues D312 and D314 were observed to hydrogen bond to core sugar moieties KDO and heptose of nearby LOS molecules. The occupancy of these hydrogen bonds was much lower, at an average of 11% of frames; the sugar moieties are further from the L2 residues and more dynamic than the phosphate head groups, so these interactions are less prevalent. In addition, these acidic residues were observed to coordinate calcium ions (Fig 3D) found in the outer leaflet. It is of note that the above interactions would not have been observed had we utilised a simplified phospholipid membrane model, and similar interactions were found when OprM was modelled in a P. aeruginosa outer membrane [46]. Finally, the hydrophobic side chain of L313 was observed to embed itself amongst the acyl tails of the LOS molecules in the hydrophobic membrane core, anchoring the L2 loops into the outer leaflet (Fig 3D).

N-Glycan dynamics & interactions

A previous MD study on the effect of N-glycans on the global structure and dynamics of non-membrane proteins indicated that glycans reduce the dynamic fluctuations of the proteins, enhancing their stability without significantly affecting local or global protein structure [58]. The effect of N-glycosylation on CmeC (and the other components of this efflux machinery) will be the focus of later work and so comparison to unglycosylated CmeC is not discussed here. We will, however, discuss the dynamics of these heptasaccharides and the interactions with species within this system.

We observe the glycans to adopt a variety of orientations relative to the principal axis of the protein (approximately parallel to the z-axis and normal to the membrane plane) (Fig 4A–4C). This is shown in the timeseries data of the angles (S5 Fig) defined between the glycan vectors (defined by Cα of the N13 or N30 residue and the C4 position of the terminal galactosamine, also defining the end-to-end length of the glycan, Fig 4D) and the principal axis of the protein. In different relative conformations these sugars can interact with different species within the system. At small angles the glycans point ‘upwards’ towards the periplasmic leaflet of the outer membrane where they can interact with the unstructured N-terminal residues (the N-terminus is lipidated and anchored to the inner leaflet) and the POPE and POPG headgroups (Fig 4A and 4B). At larger angles the glycans protrude ‘downwards’ into the periplasmic space. Here the separate heptasaccharide units may hydrogen bond to one another (Fig 4C).

Fig 4. Glycan dynamics and interactions.

Fig 4

(A) Terminal GalNAc moiety hydrogen bonds to the POPE headgroups in the inner leaflet of the membrane. (B) Bacillossamine moiety hydrogen bonds to the backbone of E11 in the unstructured N-terminus region of CmeC. (C) Glycans in the same protomer are observed to hydrogen bond to one another. (D) Vector defining the end-to-end length of the heptasaccharide and the direction in which the glycan is oriented. Defined between the Cα of the asparagine residue and the C4 position of the terminal GalNAc moiety. (E) Scatter plot of the Ψ and Φ torsion angles for each unique glycosidic linkage in the heptasaccharide, plotted in blue atop the free energy contour plots generated via metadynamics simulations by Pedebos et al (Reprinted (adapted) with permission from Ref. 60. Copyright 2015 Oxford University Press). The mean value ± the standard deviation observed for each linkage in Ref. 60 are plotted as pink rectangles on the contour plots. The glycans in our simulations show considerable exploration of the energy landscape.

The flexibility of the glycans was assessed via the end-to-end lengths and the glycosidic torsion angles defined by the linkages between saccharide moieties. The end-to-end length was observed to fluctuate over the course of the simulations, with minimum and maximum lengths of 20.40 and 29.66 Å respectively, and a mean length of 26.84 ± 1.11 Å (standard deviation). A histogram of the end-to-end lengths across the three replicates is shown in S6 Fig. This distribution of lengths implies that there is some inherent flexibility in the glycans.

To further investigate this flexibility, the glycosidic torsion angles Ψ and Φ were calculated for each glycosidic linkage for each frame across the three simulations. We define these dihedrals Ф as the angle: O5-C1-O1-CX, and Ψ as the angle: C1-O1-CX-C(X-1). Slynko et al. used NMR to assess the glycosidic torsion angles of this heptasaccharide attached to a truncated CmeA monomer, though different definitions to those defined here were used [59]. Across their 20 best structures the glycans occupied a very limited conformational space within minima on the energy surfaces for these linkages [59]. In 2015 Pedebos et al. used metadynamics to generate potential energy surfaces defined by the above torsion angles Ψ and Φ for each unique glycosidic linkage in this glycan, and employed MD simulations to investigate the equilibrium values of these linkages in a solvated, peptide-linked heptasaccharide [60]. Similarly, they found the glycans to be rigid with little variation in Ψ and Φ in their 200 ns simulation. In Fig 4E the torsion angles observed over the course of our three equilibrium simulations are plotted over the contour plots produced by Pedebos et al [60]: in contrast to both the previous simulation and NMR studies, there is considerable variation in these angles. We observe the glycans to predominantly occupy the global minima on the energy surfaces, exploring the basins on the contour maps. The exception to this is the bacillosamine-asparagine linkage which, in agreement with the molecular dynamics presented by Pedebos et al, explores only local minima [60].

Pedebos et al. present average values for each linkage with associated standard deviation [60]; whilst the average values we observe for these angles are similar, the SD in these values are considerably greater as the distribution of these values is not always unimodal (S2 Table and S7 Fig). Slynko et al. present only 20 structures for the glycosidic torsion angles [59], and Pedebos et al. present 200 ns of molecular dynamics simulations for a single glycan [60]. The data we present here is collected across 1,500 ns of simulation time (15,000 frames, each with 6 glycans, for a total of 90,000 heptasaccharide conformations). The increased variation in our results compared to previous works is likely due to this increased sampling of the conformational landscape.

CmeC shape

The β-barrels of OMFs are known to adopt different shapes when simulated in membranes under equilibrium conditions. The β-barrel of TolC has been shown to transition from a cylinder in the crystal structure [28] (PDB ID 1EK9) to a triangular prism [38] and that of OprM is strongly triangular prismatic in its crystal structure [61] (PDB ID 3D5K), which is maintained when simulated [45]. In comparison, CmeC does not appear to adopt a well-defined cylinder or triangular prism during simulations, instead adopting something closer to a hexagonal prism (Fig 5). These differences may be explained in part by the positioning of glycine residues; it has recently been shown that inwards-facing glycine residues result in sharp turns/corners in β-barrel membrane proteins [62]. The ‘corners’ defining the triangular nature of the OprM and TolC β-barrels align with the reasonably well-defined positioning of glycine residue clusters in the x-y plane. By contrast, the glycine residues in CmeC are distributed across 6 less well-defined clusters in the x-y plane of the CmeC β-barrel: one beneath each L1 loop, and one approximately at the centre of each face of the triangle defined by the three L1 loops. This aligns well with the six ‘corners’ observed in the simulated CmeC.

Fig 5.

Fig 5

Shape of the β-barrels of the outer membrane factors (A) TolC, (PDB ID: 1EK9) (B) OprM, (PDB ID: 3D5K), and (C) CmeC (PDB ID: 4MT4). Top row: Side-view of the β-barrels of these proteins from their x-ray crystal structures. Middle row: Top-down view of the β-barrels of these proteins from their x-ray crystal structures. The positions of glycine residues in this domain are shown as green spheres. Bottom row: Top-down view of the β-barrels of these proteins after simulation in a model membrane. TolC adopts a distinctly triangular structure when simulated (from its cylindrical x-ray structure). OprM maintains its triangular prismatic structure across its simulation (Reprinted (adapted) with permission from Ref 45. Copyright 2013 American Chemical Society). CmeC starts as a triangular prismatic structure and appears to adopt an approximately hexagonal prismatic structure after simulation in a membrane. The ‘corners’ of each of the β-barrels aligns with the positioning of the glycine residues.

Two constriction regions were identified by Su et al in the crystal structure of CmeC [32]: one at the periplasmic entrance, defined by residues Q412, D413, E416, and N420 in H9; and one at the extracellular exit, defined by residue R104 in L1. The channel diameter across the final 100 ns of the three equilibrium replicates was characterised using the analysis program HOLE [63]. Our findings were consistent with these constrictions, with the narrowest points in the channel aligning with residues E416 and R104 (Fig 6A and 6B).

Fig 6. Channel diameter constriction regions.

Fig 6

(A) HOLE profile of the CmeC channel. HOLE profile from the x-ray crystal structure shown in black, average profile across the final 100 ns of the three equilibrium simulations, with associated standard deviation, in orange. There is little variation is observed at the periplasmic constriction defined by residues E416 and Q412. The extracytoplsamic constriction, defined by the R104 residues of L1, shows more variation; the extracellular loops visit both the open and closed conformations freely. (B) cutaway of CmeC for scale for the HOLE profile. The two constriction regions align with the residues identified as constricting by Su et al. (30) (C) The dihedral angle determining the degree of opening of the L1 loops is defined by the three N112 alpha carbons (black) and one R104 alpha carbon (red, green, yellow). (D) Histogram of the dihedral angles observed over the three equilibrium simulations, with snapshots of loops more closed (left) and more open (right) than the XRD structure (black dashed line). (E) Circular inter- and intraprotomer hydrogen bonding network between the helices of the coiled coil domain. I: Interprotomer (H5-H8’) salt bridges R370-E226, N385- E212, R395-E201. II: Intraprotomer (H8-H9) hydrogen bond W421- E390. III: Intraprotomer (H9-H4) Hydrogen bonding and salt bridges K432-E171, N429- N172, Q161-D441, N172/N168-N430. IV: Intraprotomer (H4-H5) salt bridge K222-E173.

The extracellular constriction displays considerable variation (Fig 6A). During the equilibrium simulations the L1 loops sample conformations both more and less ‘open’ than those in the crystal structure (Fig 6C and 6D). This is determined via the dihedral angles defined between the three N112 Cα atoms and a single R104 Cα atom (Fig 6C); in the crystal structure the average dihedral across the three protomers is 90.7°, but over the course of the equilibrium simulations angles as small as 32.3° and as large as 130.1° are sampled. This is similarly observed in the simulation of TolC and OprM, though the loops of these homologues open to a greater extent and sample a greater range of angles [41,45]. This may be a result of the use of LOS in our system, where the bulky LOS headgroups and core oligosaccharides sterically hinder the further opening of the loops. Additionally, this reduced range may be due to the presence of the N-glycans, which are known to reduce protein dynamics [58]. Despite this, our data further support the hypothesis that OMFs are not gated at the extracellular exit as the loops freely explore open and closed conformations.

From the crystal structure, Su et al suggest a circular hydrogen bonding pattern in which residues E416 and Q412 of an adjacent protomer interact to form the core of the periplasmic constriction [32]. However, the salt bridge between the side chains of these residues is not persistent across the simulations; hydrogen bonding between the amide of Q412 and the carboxylate of a neighbouring E416 is observed in just 1% of the equilibrium trajectory frames. Despite this, the E416 and Q412 residues do still constitute the narrowest constriction of the channel with an average effective diameter of just 4–5 Å in this region. As shown in Fig 6A, there is very little variation in the channel radius in the periplasmic domain (coiled-coil and alpha barrel regions). Several intra- and interprotomer salt bridges and hydrogen bonds in a circular network may be promoting this closed conformation (Fig 6E). Intraprotomer hydrogen bonds were observed across the simulations between H9 and H4 (K432-E171, N429-N172, Q161-D441); H5 and H4 (K222-E173); H9 and H8 (W421-E390). Interprotomer salt bridges R370-E226’, R395-E201’, and N385-E212’ (H8-H5’) were also observed in every replicate.

Previous simulation and mutational studies of OMFs have suggested an ‘iris-like’ motion of the coiled-coil domain to allow the periplasmic entrance to open, requiring a major conformational rearrangement at a high energetic cost. Mutational and Markov state modelling studies have demonstrated that for the periplasmic entrance of TolC to open, interprotomer interactions must be disrupted, but intraprotomer interactions may remain intact [39,44]. We do not observe a twisting motion in any of the three equilibrium replicates, nor do we observe any correlated disruption of the inter- and intraprotomer hydrogen bonding network.

Despite simulating this system for a total of 1.5 μs, our simulations are still relatively short for such a large and complex system: simulation studies of TolC in smaller and simpler membrane systems demonstrated that submicrosecond simulations were insufficient to adequately sample the equilibrium behaviour of the periplasmic gate [43]. To prevent the uncontrolled diffusion of solutes, OMFs adopt a closed conformation when not coupled to their periplasmic adaptor partners: in vivo this protein is coupled to the PAP CmeA, and likely interacts with the peptidoglycan cell wall [53,64,65] and potentially other proteins/efflux machinery [66]. We have simulated CmeC as an isolated membrane protein so it is no surprise that we only observe the closed state under equilibrium conditions. Another factor is the cations in our model, which is discussed in the following section.

Cation binding sites within the channel

Cation binding sites have been identified in the OMFs TolC and OprM [67,68], and simulations have shown that for the periplasmic end of the wild-type proteins to open in silico these cations must be removed from the system [41,45]. Cations have also been identified as potential orthosteric inhibitors of outer membrane factors due to their strong coordination by the conserved rings of acidic residues in the coiled-coil domain [67,69,70]. Here we identify regions within CmeC that display substantial cation density across the equilibrium simulations, and observe cations contributing to the closed conformation of the coiled coil domain.

Initially we expected the solvated potassium ions to be the prime candidate for cation coordination within the channel. However, we identified very little potassium ion density within CmeC (S8 Fig). Unlike previous simulations studying OMF dynamics (which have used symmetric phospholipid bilayers and Na+ and Cl- ions in solution) our model included LOS in the outer leaflet with divalent calcium ions (necessary for outer membrane integrity [7181]) in addition to K+ and Cl- in solution; using the VMD plugin VolMap we identified Ca2+ density within the CmeC channel across the equilibrium simulations (Fig 7A). During equilibration and production stages of the simulations calcium ions have escaped the LOS headgroups, and due to periodic replication of the simulation system were able to enter the protein from both the extracellular and periplasmic ends. Due to the increased coulombic attraction between Ca2+ and the carboxylate residues (compared to K+), calcium ions are coordinated preferentially. The calcium ion density is primarily situated proximal to acidic residues D413, E416, E353, E107, D86, and D77. Table 1 lists the proportion of equilibrium trajectory frames in which a calcium ion was coordinated by each of these acidic residues (in at least one protomer).

Fig 7. Acidic residues within the channel coordinate calcium ions.

Fig 7

(A) Calcium ion density (green surface) located close to acidic residues (VDW, labelled) within the CmeC channel. Considerable calcium ion density was found near residues D413, E416, E353, D77, D86, and E107. (B) Acidic residues above the coiled-coil region coordinate calcium ions in a 1:1 stoichiometry. Here, two calcium ions (green spheres) are bound to two of the three E353 residues. (C) The calcium ions bound to E416 see drastic changes to their hydration shell as 1 (green), 2 (yellow) or all 3 (red) acidic residues coordinate a single cation. Coordination is coupled with the triangular cross-sectional area: as more E416 residues coordinate, the triangular cross-sectional area defined by the E416 alpha carbons decreases. TCA defined in the x-ray crystal structure shown as a dashed black line.

Table 1. Proportion of trajectory frames in which selected acidic residues are observed to coordinate a calcium ion.

Residue % Frames containing interaction Change in %
Equilibrium MD CDCA steered MD
D413 62 72 +10
E416 96 99 +3
E220 16 25 +9
E107 91 97 +6
E353 89 92 +3
D86 24 42 +18
D77 32 91 +59

Calcium ions may be coordinated by up to three acidic residues simultaneously (one from each protomer). For aspartate/glutamate residues in the β- and α-barrel regions of the protein (e.g. E353), the internal diameter of CmeC is such that the acidic residue from only one protomer can coordinate a single calcium ion at any given time (Fig 7B). By contrast, the lower coiled-coil region is sufficiently narrow that acidic residues from multiple protomers can coordinate the same calcium ion; in all replicates, two E416 residues consistently coordinate a single calcium ion, and occasionally all three residues will coordinate this central ion (Fig 7C). This additional level of coordination results in calcium ions remaining bound in this region for hundreds of nanoseconds at a time.

We note here that previous computational studies have identified systematic overestimation of protein-ion affinities for cations in the CHARMM force fields using single-point cation models [82,83]. Updates to the force field in late 2020 attempted to rectify such issues by increasing the Lennard-Jones parameter, σ, for carboxylate-cation interactions [84]. A similar change to non-bonded parameters has been shown to improve binding affinities dominated by cation-π interactions [85]. We have used the CHARMM36m force field with these updated Lennard-Jones parameters; to our knowledge, this model is appropriate for the scope of this paper. However, should binding free energies be calculated, a polarisable or multi-point ion model would be most appropriate.

Coordination of calcium ions by acidic residues near the periplasmic entrance causes a contraction in the triangular cross-sectional area defined by Cα of the E416 residues (TCAE416) (Fig 7C). The increased coordination is also reflected in the reduced solvation sphere (number of water molecules with at least one constituent atom within 3 Å of the ion’s centre of mass) for the bound calcium ion. A calcium ion in the CHARMM36m force field using the TIP3P water model displays an average solvation sphere of 7–8 water molecules, in agreement with experimental data [86]. Coordination to one, two, or three acidic residues within CmeC results in solvation spheres of 5–6, 4–6 and 2–3 water molecules respectively (Fig 7C).

To further assess the link between this coordination and tight periplasmic constriction, additional simulations were undertaken in which the cations within the channel were removed. Chloride ions were also removed from solution to neutralise the net positive charge, and these new systems were simulated in duplicate. When only calcium ions were removed (and remaining calcium ions restrained to prevent re-entry into the channel), there was a small increase in the average TCAE416 (Table 2). In these simulations, potassium ions can become coordinated at sites previously occupied by calcium ions. This includes the rings of acidic residues at the periplasmic constriction; in lieu of calcium ions, potassium ions can hold this end of the protein in a closed conformation.

Table 2. Average TCAE416 (with associated standard deviation) from the simulations.

For the equilibrium simulations, TCA is calculated from the final 100 ns over the three replicates. For systems where cations have been removed, TCA is calculated from the final 20 ns over the two replicates.

Equilibrium simulations Ca2+ removed Ca2+ and K+ removed
TCAE416 / Å2 63.40 ± 3.82 67.09 ± 4.23 115.36 ± 9.49

When both potassium and calcium ions were removed (and all remaining cations restrained) there was a large increase (+82%) in the average TCAE416 (Fig 8A) as there is no longer a central cation holding the coiled-coil tightly closed. This is also reflected in the protein backbone RMSD (S9 Fig) and the pore radius profile (Fig 8C). This increase is consistent with simulation studies in which the removal of sodium ions at the periplasmic end of TolC and OprM caused an increase in TCA at D374 and D416 (both corresponding to E416 in CmeC) respectively [41,45]. This increase in TCA is driven primarily by the outwards motions of H8 and H9, as shown in Fig 8B. For further opening of the coiled coil domain in an iris-like fashion, interprotomer interactions must be disrupted [43,44]; as with our equilibrium simulations we do not observe any correlated disruption of interprotomer (or intraprotomer) hydrogen bonding networks in the coiled-coil domain (S10 Fig). These data further reinforce the hypothesis that the periplasmic entrance of OMFs is regulated both by interprotomer interactions [43,44] and by cations [37,45].

Fig 8. Cation removal allows the coiled-coil domain to open.

Fig 8

(A) Timeseries of TCAE416 when only calcium ions are removed from the channel and remaining calcium ions restrained (pink), and when all cations within the channel are removed and all remaining cations restrained (yellow). Removing all cations within the channel allows the coiled coil region to open. (B) Porcupine plot indicating the direction and magnitude of motion between the initial, closed conformation of CmeC to the most open structure observed in these simulations (Ca2+ & K+ removed, replicate 1 at t = 36.5 ns). Bottom-up view of the coiled-coil domain. Colour scale from 0.06 Å (blue) to 12.13 Å (red). (C) Channel radius profile for the most open conformation, with the XRD profile for comparison. The channel radius at the periplasmic entrance has increased considerably. (D) Bottom-up view of the periplasmic entrance to CmeC in the initial equilibrated conformation (left) and the most open conformation (right). Distances between E416 Cα atoms of E416 residues displayed (Å).

Substrate translocation

CmeABC is known to extrude a variety of structurally unrelated compounds, including various antibiotics and bile salts [27,8790]. To investigate the translocation of substrates through CmeC we used steered molecular dynamics (SMD) to pull erythromycin (a macrolide antibiotic and the therapy of choice for Campylobacter infections [91]) and chenodeoxycholic acid (CDCA, a bile acid commonly found in avian species [92]) through the channel (Fig 1C and 1D).

Both substrates successfully entered and translocated the channel with the aid of the external pulling force. Force profiles for both substrates indicate that entry to CmeC is the greatest barrier to translocation (Fig 9A). The force required to pull CDCA is greater than that for erythromycin by around 50%, despite erythromycin being a larger molecule. In aqueous solution erythromycin is uncharged, whereas CDCA is deprotonated to yield an anionic species. This constriction in CmeC is primarily acidic residues (most notably E416 and D413), and the interior surface of CmeC is ‘strikingly electronegative’ [32] (Fig 1B); CDCA faces a greater barrier to entry in the form of electrostatic repulsion.

Fig 9. Force and substrate hydration profiles for translocation of erythromycin and CDCA through CmeC.

Fig 9

(A) Average force profile for the translocation of each substrate with associated standard deviation, with the HOLE profile for reference. The greatest barrier to translocation is the tight periplasmic entrance. There is no great force barrier at the extracellular exit, implying that there is no gating at this end. (B) Average hydration profiles for the substrates as they translocate the channel with associated standard deviation, with the HOLE profile for reference. Average hydration shell population in solution indicated for each substrate as a vertical dashed line. Both substrates must lose a considerable proportion of their hydration shell to translocate, with the greatest decrease at the periplasmic entrance.

It is of note however that we did not observe either substrate to enter the channel via the conventional route: we would expect the substrates to enter the channel through the centre, but instead we observed these molecules to enter in gaps defined by the periplasmic ends of helices H4, H5, H8 and H9 (Fig 10A). This resulted in a temporary increase in TCAE416 as helices moved to accommodate the substrate (Fig 10B). Despite this, the translocation of the substrates did not appear to disrupt the intra- and interprotomer hydrogen bonding networks, though E416-Ca2+ coordination was disrupted. As the substrates move through this constriction, H9 moves outwards and the glutamate residues from different protomers are separated; only one E416 coordinated a calcium ion during this time, if at all.

Fig 10. Translocation of Erythromycin through CmeC.

Fig 10

(A) Entry of erythromycin (shown as overlaid white, purple, and cyan transparent structures) occurs between the coiled-coil helices (shown in red, orange, green, and yellow New Cartoon representation) rather than through the central constriction defined by the side chains of the E416 residues (shown in red VDW). This entry pathway is also observed for CDCA. (B) Timeseries of the triangular cross-sectional area defined by the Cα atoms of the three E416 residues (TCAE416). Erythromycin enters the channel within the first 35 ns, which disrupts the coordination of E416 residues to the central calcium ion, causing the protomers to move apart and the TCA to increase. When erythromycin has passed this constriction region the TCA returns to a value below that in the x-ray structure as multiple E416 residues coordinate the central calcium ion. (C) Cutaway of CmeC (orange New Cartoon representation) with every 5th frame for erythromycin (licorice, coloured by atom name) from three replicates overlaid. Hydrogen atoms not shown for clarity. Erythromycin displays no clear orientation preference on translocation.

When simulated in the CHARMM36m force field using the TIP3P water model, erythromycin has an average solvation sphere of ~57 water molecules, and that of CDCA is ~39 waters. In order to enter and translocate the channel the substrates must shed water molecules. The decrease in water molecules around each substrate is heavily correlated to the pore radius (S11 Fig); at the narrowest constriction point, the average number of water molecules around erythromycin decreases by 35%, and around CDCA by 49% (Fig 9B). As the channel increases in radius, hydration increases for both substrates, though the solvation sphere contains fewer waters than in solution at all points during translocation.

Substrate orientation preference

It has previously been shown that outer membrane proteins can enforce orientation requirements for substrate passage [49,93]. By overlaying every nth frame from the steered MD trajectories we can visualise how the orientation of each substrate changes during translocation. Erythromycin shows no clear preferences/requirements in any of the SMD simulations: there are no regions within CmeC in which erythromycin displays a consistent orientation (Fig 10C). An additional plot was generated to show the clustering of a particular atom (a hydroxyl oxygen) over all of the trajectories (S12 Fig). Erythromycin is polar, but uncharged at physiological pH. Its polar functional groups (hydroxyls, esters, and an amine) are distributed across the molecule, which is reflected in the electrostatic profile of this molecule (S13 Fig) As such, erythromycin is capable of hydrogen bonding with the channel residues regardless of its orientation, thus showing no clear preference on translocation.

CDCA has only three polar groups: two hydroxyl groups, and a carboxylic acid moiety which is deprotonated at physiological pH. The resulting anionic carboxylate moiety (reflected in the electrostatic profile, S14 Fig) will therefore dominate the interactions between CDCA and the predominantly anionic interior surface of CmeC. Across the nine SMD simulations in which this substrate is pulled through the channel, CDCA shows orientation preference at several positions; the carboxylate moiety of the molecule orients towards the side chains of channel-lining residues (Fig 11A). An additional plot was generated to show the clustering of a particular atom (a carboxylate oxygen) over all of the trajectories (S15 Fig). Interestingly, these regions of preferred orientation correlate with the positions of acidic residues that line the channel. This is explained by the presence of the multivalent Ca2+ ions in the system: the carboxylate moieties of both CDCA and aspartate/glutamate residues can simultaneously coordinate a single calcium ion (Fig 11D). Across the 9 trajectories, we observe CDCA to coordinate a calcium ion in 64% of frames, with an average coordination lifetime of 3.6 ns (maximum observed lifetime of 23.5 ns). 21% of these coordination interactions were transient (lasting less than 0.5 ns), though these short interactions constitute just 1% of the total interaction time. In turn we observe these CDCA-coordinated calcium ions to be simultaneously coordinated by acidic residues lining CmeC in 20% of the total frames. When these CDCA-Ca2+-ASP/GLU interactions are broken on CDCA translocation, CDCA abstracts the calcium from the acidic lining residue in 67.7% of unbinding events.

Fig 11. Translocation of CDCA through CmeC.

Fig 11

(A) Cutaway of CmeC (orange New Cartoon representation) with every 5th frame for CDCA (licorice, coloured by atom name, with carboxylate oxygen atoms shown as spheres) overlaid from one representative SMD simulation. CDCA displays orientation preference in several regions, generally when close to acidic lining residues. (B) A snapshot from a steered MD simulation. CDCA can coordinate calcium ions that are bound to acidic residues within the CmeC channel. They can simultaneously hydrogen bond to nearby basic residues, those these interactions are most commonly transient. (C) A snapshot from an equilibrium simulation. CDCA coordinates a calcium ion bound at the periplasmic entrance. This interaction with the tightly bound calcium is much longer-lived than interaction with bound calcium ions at wider points in the channel. (D) A snapshot from a steered MD simulation. CDCA coordinates an aspartate-bound calcium as it translocates. (E) A snapshot from an equilibrium simulation. In this replicate CDCA did not coordinate a calcium ion, and instead formed a salt bridge with K444 multiple times, with an average lifetime of 17 ns.

The presence of CDCA within the channel also appears to promote the coordination of calcium ions to these acidic lining residues: as shown in Table 1 the proportion of frames in which a calcium ion is coordinated is somewhat increased in the SMD trajectories when compared to the equilibrium simulations. The phenomenon of cation coordination increasing to cationic to acidic residues in the presence of CDCA within the channel is striking and reproducible. While these changes are statistically significant for D77 and E416 (p values of 0.00171 and 0.00672 respectively) longer trajectories/larger data sets are needed to confirm whether the increase in ion coordination is a general phenomenon or specific to some sites. We note that E416 is part of a ring of acidic residues at the periplasmic entrance that is conserved across OMFs, while D77 is not conserved.

We do observe salt bridges between CDCA and the basic residues lining CmeC, though only in 6.3% of trajectory frames. Basic residues are found predominantly in the α- and β-barrel domains and often positioned close to an acidic residue where their side chains become less readily available to translocating substrates by engaging in salt bridges. Additionally, by the time CDCA reaches these basic residues it is often already coordinating a calcium ion, making interaction with these cationic side chains less favourable.

Full umbrella sampling with adequate convergence for the calculation of a PMF profile was deemed unfeasible for such a long and wide channel. Instead, several equilibrium simulations were initiated from snapshots with CDCA within the channel to further assess CDCA-CmeC interactions. A separation of approximately 1 nm was used between windows, with additional replicates where CDCA is proximal to the acidic residues where an orientation preference was observed in SMD simulations. In these equilibrium simulations we observe a similar trend in interactions with the acidic lining residues. Over the course of the 23 equilibrium simulations (totalling 2.78 μs) CDCA coordinates a calcium ion in 78% of frames, with 39% of the total frames displaying a calcium ion coordinated to both CDCA and an acidic residue simultaneously.

The mean lifetime of CDCA-Ca2+ coordination is 28 ns. 13% of interactions were transient (but constituting only 0.1% of the total interaction time), and coordination lifetimes of up to 151 ns were observed. In turn, these CDCA-coordinated Ca2+ ions are also coordinated by ASP/GLU residues. On average, CDCA remains coordinated to the GLU/ASP-bound calcium ions for 7 ns. 31% of these interactions were transient, constituting 0.8% of the total interaction time. A maximum interaction lifetime of 106 ns was observed where CDCA coordinated a calcium bound to the E416 and D413 residues at the periplasmic entrance (Fig 11C); the four replicates that included this interaction saw an average lifetime of interaction of 22 ns, with CDCA coordinating this tightly bound calcium in 80% of frames. When CDCA-Ca2+-GLU/ASP interactions are disrupted the calcium ion can remain bound to the GLU/ASP residue, or be abstracted by CDCA. In 61.4% of unbinding events CDCA abstracts the calcium.

Interaction with basic residues is observed, though again these interactions are less prevalent than those with the acidic residues (6.2% of frames). In the majority of cases the interaction with basic residues is transient and/or occurs simultaneously with coordination to a calcium and nearby acidic residue (Fig 11B). The exception to this is a single equilibrium simulation in which the starting conformation places CDCA (without a coordinated calcium ion) proximal to K444 (Fig 11E). In this case CDCA is initially free in solution within the channel, interacts with K444 multiple times across the simulation (average lifetime of 17 ns), and is not observed to coordinate a calcium ion (and in turn interact with acidic residues) despite being proximal to D441. However, orientational preference around this basic residue was not observed in the SMD simulations; the significance of this interaction remains to be determined.

An acidic ladder for an anionic substrate?

Taking these results in combination, we can begin to build a picture for how the anionic CDCA translocates this predominantly anionic channel. Equilibrium MD showed that acidic sites within the channel can coordinate calcium ions from solution, partially neutralising the anionic nature of the channel lining. When CDCA is steered through the channel, we observe its carboxylate moiety to coordinate these bound calcium ions, as well as calcium ions in solution, resulting in several regions of preferred orientation for the CDCA molecule within the channel. CDCA often abstracts this calcium ion on translocation (67.7% of unbinding events in SMD, 61.4% in equilibrium MD). We propose that CDCA is utilising the calcium ions to climb the ladder of acidic residues that line the interior surface of CmeC.

There is precedence for such a ladder mechanism in the translocation of arginine through the outer membrane protein OprD from P. aeruginosa [93]: steered MD, docking, and equilibrium molecular dynamics revealed a distinct orientational requirement along the permeation pathway in which the carboxylate moiety of free arginine interacted with a previously-identified basic ladder of arginine residues. Here we note that while CDCA does not display an orientational requirement for translocation, there are clear areas of preference observed in all the SMD replicates that suggest this coordination to protein-bound calcium ions is important. Whether this mechanism of translocation applies to other anionic substrates, such as the fluoroquinolone family of antibiotics, and how cationic substrates traverse the channel remain to be investigated.

Limitations

As with any biomolecular simulation study, adequate sampling is of concern. Even after 500 ns of simulation, CmeC has not reached an equilibrium conformation in any of the three equilibrium replicates. Longer simulations are required to reach an equilibrium state, but given the size of this system it is unclear how long this may take: even when a simulation was extended to 1.25 μs the RMSD was still rising. However, principal component analysis indicates that the equilibrium simulations sampled different conformational states, unique from the X-ray structure.

We have simulated CmeC as an isolated membrane protein, when in vivo this protein would be coupled to CmeB via CmeA and likely interacts with the peptidoglycan cell wall. OMFs are known to adopt a closed state when not coupled to their PAP partner to avoid uncontrolled movement of species into and out of the cell; in the presence of cations we have only observed the closed state of CmeC during our simulations. CmeC may also interact with other OMPs or efflux systems [66] which have been omitted. Our outer membrane model, despite modelling the LOS in the outer leaflet, is likely still a simplification: in 2020 Cao et al demonstrated that the phospholipodome of C. jejuni contained a substantial proportion of lysophospholipids [56], which may influence protein structure and dynamics but have not been included in our model.

Whenever considering drug/small molecule binding to a protein or translocation pathways it is desirable to compute free energies for unambiguous comparisons. We have performed a number of steered MD simulations here and the temptation is to exploit the Jarzynski equality to extract free energies from the force profiles [94]. However the large system size (close to 1 million atoms) [95], insufficient simulation lengths with only a single pulling rate [96,97], and the importance of electrostatics in the protein-substrate interactions [96] precludes this.

Conclusions

The equilibrium simulations presented here show that CmeC behaves in a similar fashion to other simulated OMFs TolC and OprM: we observe a periplasmic gate which displays very little dynamic nature, held tightly closed by cations and inter- and intraprotomer hydrogen bonding networks; and a highly dynamic extracellular constriction in which extracellular loops visit both open and closed conformations. The N-glycans display greater flexibility than previous studies have suggested. Within the channel, we identify several acidic residues that coordinate calcium ions from solution and show that the coordination of cations in the coiled coil region contributes to the closed conformation of CmeC. Steered MD showed that the acidic sites lining the channel were areas in which the anionic substrate CDCA displayed a clear orientation preference. CDCA was observed to coordinate the bound calcium ions, and we propose that this substrate coordinates these calcium ions to ‘climb’ its way up the channel interior.

Methods

All molecular dynamics simulations were performed in the CHARMM36m force field [98,99] with TIP3P water [100] in the GROMACS 2019.4 package [101,102]. The LINCS algorithm was utilised to constrain all bonds [103]. Van der Waals interactions were smoothed at distances beyond 1.0 nm to a cut-off at 1.2 nm. Long-range electrostatics were treated using Particle Mesh Ewald [104] with a cut-off of 1.2 nm. The system was coupled to a heat bath at 315.15 K using the velocity-rescale thermostat [105] at equilibration and production stages (τT = 1.0 ps). Analyses were performed using GROMACS and MDAnalysis utilities [106109]. Molecular graphics were generated in VMD 1.9.4a51 [110].

System construction

The CmeC X-ray structure was obtained from the RCSB Protein Data Bank (accession code: 4MT4) [32]. Missing C-terminal residues were added using MODELLER [111]. The CHARMM-GUI Membrane Builder Module [55,112] was used to modify the protein structure with N-terminal lipidation and appropriate N-glycosylation at residues N13 and N30 in each protomer, then to embed the β-barrel domain of CmeC in a model C. jejuni outer membrane (1:1 ganglioside mimicry 1 and 1a LOS in the outer leaflet, and 4:1 POPE and POPG in the inner leaflet) [54,55]. This protein-membrane system was solvated in 150 mM KCl with additional calcium ions (equating to a concentration of 125 mM) associated with the LOS core sugar phosphates. The system was energy minimised in 50,000 steps using the steepest descent algorithm [113], then equilibrated sequentially using 2 NVT phases and 4 NPT phases with decreasing position restraints at each phase (Table 3). All NPT phases coupled the system to a pressure bath at 1 bar using the semi-isotropic Berendsen scheme [114] (τp = 5.0 ps, compressibility = 4.5x10-5 bar-1).

Table 3. Position restraints, timestep, and duration of the equilibration phases.

Equilibration Phase Position restraints / kJ mol-1 nm-2 dt / fs Duration / ns
Protein Backbone Protein Sidechain Lipid Headgroups Dihedrals
NVT1 4000 2000 1000 1000 1 0.125
NVT2 2000 1000 400 400 1 0.125
NPT1 1000 500 400 200 2 0.5
NPT2 500 200 200 200 2 0.5
NPT3 200 50 40 100 2 0.5
NPT4 50 - - - 2 0.5

Equilibrium molecular dynamics

Three replicates of this system were generated. One simulation used the final frame of the 6th equilibration phase as the initial conformation. The additional replicates were each heated to 330 K for 20 ns with position restraints of 4,000 and 2,000 kJ mol-1 nm-2 applied to the protein backbone and sidechains respectively to induce new starting configurations for the membrane lipids. Each system was simulated at 315.15 K for 500 ns. Pressure was maintained at 1 bar using the semi-isotropic Parrinello-Rahman coupling scheme [115,116]. The contents of this system, and all subsequent simulation systems, can be found in Table 4.

Table 4. Number of each species present in each simulation system.

Equilibrium MD Ca2+
removal
Ca2+ & K+ removal Erythromycin SMD CDCA SMD/MD
CmeC Protomers 3 3 3 3 3
LOS GM1 108 108 108 108 108
LOS GM1a 108 108 108 108 108
POPE 551 551 551 551 551
POPG 136 136 136 136 136
K + 841 841 827 841 842
Cl - 669 651 637 669 669
Ca 2+ 702 693 693 702 702
TIP3P water 245,701 244,701 244,701 244,701 244,700
Erythromycin 0 0 0 1 0
CDCA 0 0 0 0 1
Total Atoms 964,998 964,971 964,943 965,116 965,063

Cation removal

The final frame of one replicate of the equilibrium system was extracted and used as the starting conformation for further simulations to assess the role of cations in the constriction at the periplasmic entrance. Two systems were generated: in the first, just calcium ions within the channel were removed (remaining calcium ions restrained, 1,000 kJ mol-1 nm-2), and in the second all calcium and potassium ions within the channel were removed (all remaining cations restrained, 1,000 kJ mol-1 nm-2). Chloride ions were removed from solution to neutralise the systems. Both systems were energy minimised in 5,000 steps using the steepest descent algorithm. Each system was simulated in duplicate for 80 ns.

Steered molecular dynamics

Erythromycin and chenodeoxycholic acid (CDCA) molecules were generated in the CHARMM36m force field using CHARMM-GUI’s Ligand Modeler module [117] and energy minimised in 5,000 steps using the steepest descent algorithm. Each molecule was manually positioned below the periplasmic entrance to CmeC in three different orientations. These protein-substrate structures were subsequently modified with the appropriate N-glycans and N-terminal lipids, embedded in a model membrane and solvated as described in the previous system construction. The systems were energy minimised and equilibrated using the same protocol as the equilibrium systems.

A harmonic spring of force constant 1,000 kJ mol-1 nm-2 was attached to the centre of mass of each substrate. This was pulled along the z-axis (perpendicular to the membrane) at a constant velocity of 0.1 nm ns-1. No restraints were applied to the substrates in the x and y dimensions. A total of nine replicates were generated for each system, with each simulation lasting 160–170 ns. For the CDCA system, snapshots were taken with CDCA at various positions within the channel, and these were used as initial configurations for subsequent equilibrium simulations, each run for a minimum of 100 ns; a total of 23 equilibrium simulations were run with CDCA within the channel.

Electrostatic profiles of substrates

The electrostatic potentials of erythromycin and the deprotonated CDCA molecules were calculated using the density functional theory package, ONETEP [118,119], using the PBE exchange-correlation functional [120], augmented with Grimme’s D2 dispersion correction [121]. Open boundary conditions via real-space solution of the electrostatics were used in a simulation cell with dimensions 5 nm ✕ 5 nm ✕ 5 nm. Norm-conserving pseudopotentials were used for the core electrons, and the psinc basis set, equivalent to a plane wave basis set with a kinetic energy cut-off of 800 eV, was employed. 8.0 Bohr localisation radii were used for the nonorthogonal generalised Wannier functions (NGWFs).

Supporting information

S1 Fig. Chemical structure of the heptasaccharide attached to N13 and N30 in CmeC.

(TIF)

S2 Fig. Timeseries data of the simulation box dimensions.

X and Y dimensions of the box are coupled (semi-isotropic pressure coupling used). Box dimensions are stable after ~300 ns.

(TIF)

S3 Fig. Top: Root-mean-square deviation (RMSD) of the protein backbone in each replicate.

In all three replicates the RMSD is still increasing at 500 ns, indicating that CmeC is not yet fully equilibrated. Bottom: When one replicate was extended to 1250 ns, the backbone RMSD continued to increase.

(TIF)

S4 Fig. Secondary structure analysis (STRIDE) for CmeC from one replicate across the 500 ns simulation.

(TIF)

S5 Fig

Timeseries data of the angle defined between the protein principal axis (approximately parallel to the z-axis) and the glycan vector (defined in Fig 4E). A wide variety of relative orientations are observed.

(TIF)

S6 Fig. Distribution of end-to-end lengths for the heptasaccharide.

Ther is considerably more variation in this value than would be expected from a ‘rigid-rod’.

(TIF)

S7 Fig. Distribution of Ψ and Φ values for each glycosidic linkage in the heptasaccharide.

Data from our equilibrium simulations plotted in blue. Values defined by the mean ± standard deviation in Ref 60 for each linkage shaded in yellow

(TIF)

S8 Fig. Potassium ion density proximal to CmeC.

A small amount of potassium ion density is located near D86 within the channel.

(TIF)

S9 Fig. Comparison of protein backbone RMSD from equilibrium simulations, systems where calcium ions were removed from within CmeC, and systems where both calcium and potassium ions were removed from within CmeC.

Systems where cations were removed saw increased RMSD values compared to equilibrium simulations, though this is most pronounced in systems where both calcium and potassium ions were removed.

(TIF)

S10 Fig. Hydrogen bond count in the coiled-coil region of CmeC (hydrogen bonds between different helices only) for replicate 1 of the system with both calcium and potassium ions removed from within the channel.

Dashed pink vertical lines indicate times at which there was a peak in TCAE416; there is no clear increase or decrease in the number of these hydrogen bonds (inter- or intraprotomer) correlated with peaks in TCA.

(TIF)

S11 Fig. Scatter plots of the force against the hydration shell population at positions within the CmeC channel, with points coloured by the channel radius, demonstrating correlation between the force required for translocation and both the channel radius and the population of the hydration shell.

(TIF)

S12 Fig. Occupancy map for a hydroxyl oxygen in Erythromycin (right, highlighted) over the steered MD simulations.

The occupancy is delocalised in the channel. The only clear localised region of high occupancy is at the periplasmic entrance, where the rotational freedom of erythromycin is limited due to the narrow channel diameter.

(TIF)

S13 Fig. Electrostatic profile of erythromycin.

Colour scale: -1 V in red to +1 V in blue. Electronegative groups are distributed around the erythromycin molecule.

(TIF)

S14 Fig. Electrostatic profile of CDCA.

Colour scale: -1 V in red to +1 V in blue. While there are three electronegative functional groups in CDCA, the carboxylate group dominates.

(TIF)

S15 Fig. Occupancy map for a carboylate oxygen in chenodeoxycholic acid (right, highlighted) over the steered MD simulations.

There are several localised regions of high within the channel. These align with acidic lining residues where CDCA is coordinating a bound protein-bound calcium ion.

(TIF)

S1 Table. Percentage variance explained by the first 10 eigenvectors identified via principal component analysis.

(PDF)

S2 Table. Mean values of Ψ and Φ for each linkage in the heptasaccharide, with associated standard deviation.

(PDF)

Acknowledgments

The authors acknowledge access to the following High Performance Computing resources: Iridis 5 at the University of Southampton and the ARCHER2 UK National Computing Service to which access was granted via HECBioSim, the UK High-End Computing Consortium for Biomolecular Simulation (EPSRC grant no. EP/R029407/1).

Data Availability

All input files necessary to run the simulations, and all resulting trajectories discussed in the paper are available on Zenodo: https://doi.org/10.5281/zenodo.7041473.

Funding Statement

K.E.N. is supported by a Ph.D. Studentship from the Engineering and Physical Sciences Research Council (Project No. 2446840). S.K. is supported by an EPSRC Established Career Fellowship (EPSRC grant no. EP/V030779/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.World Health Organization. State of the art of new vaccine and development. World Health Organization; 2006. Report No.: WHO/IVB/06.01. [Google Scholar]
  • 2.Allos BM, Iovine NM, Blaser MJ. Campylobacter jejuni and Related Species. In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. Elsevier Inc.; 2014. p. 2485–2493.e4. [Google Scholar]
  • 3.Kaakoush NO, Miller WG, De Reuse H, Mendz GL. Oxygen requirement and tolerance of Campylobacter jejuni. Res Microbiol. 2007. Oct 1;158(8):644–50. doi: 10.1016/j.resmic.2007.07.009 [DOI] [PubMed] [Google Scholar]
  • 4.Awad WA, Hess C, Hess M. Re-thinking the chicken–Campylobacter jejuni interaction: a review. Avian Pathol. 2018. Jul 4;47(4):352–63. doi: 10.1080/03079457.2018.1475724 [DOI] [PubMed] [Google Scholar]
  • 5.Blaser MJ, Taylor DN, Feldman RA. Epidemiology of Campylobacter Jejuni Infections. Epidemiol Rev. 1983. Jan 1;5(1):157–76. doi: 10.1093/oxfordjournals.epirev.a036256 [DOI] [PubMed] [Google Scholar]
  • 6.Public Health England UK. A microbiological survey of campylobacter contamination in fresh whole UK-produced chilled chickens at retail sale (Y6). Food Standards Agency; 2021. Nov. [Google Scholar]
  • 7.Allan PD, Palmer C, Chan F, Lyons R, Nicholson O, Rose M, et al. Food safety labelling of chicken to prevent campylobacteriosis: consumer expectations and current practices. BMC Public Health. 2018. Mar 27;18(1):414. doi: 10.1186/s12889-018-5322-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Friedman CR, Hoekstra RM, Samuel M, Marcus R, Bender J, Shiferaw B, et al. Risk factors for sporadic Campylobacter infection in the United States: A case-control study in FoodNet sites. Clin Infect Dis Off Publ Infect Dis Soc Am. 2004. Apr 15;38 Suppl 3:S285–296. doi: 10.1086/381598 [DOI] [PubMed] [Google Scholar]
  • 9.Little CL, Gormley FJ, Rawal N, Richardson JF. A recipe for disaster: outbreaks of campylobacteriosis associated with poultry liver pâté in England and Wales. Epidemiol Infect. 2010. Dec;138(12):1691–4. [DOI] [PubMed] [Google Scholar]
  • 10.Gallay A, Bousquet V, Siret V, Prouzet-Mauléon V, Valk H de, Vaillant V, et al. Risk factors for acquiring sporadic Campylobacter infection in France: results from a national case-control study. J Infect Dis. 2008. May 15;197(10):1477–84. doi: 10.1086/587644 [DOI] [PubMed] [Google Scholar]
  • 11.Stafford RJ, Schluter PJ, Wilson AJ, Kirk MD, Hall G, Unicomb L. Population-Attributable Risk Estimates for Risk Factors Associated with Campylobacter Infection, Australia. Emerg Infect Dis. 2008. Jun;14(6):895–901. doi: 10.3201/eid1406.071008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Deming MS, Tauxe RV, Blake PA, Dixon SE, Fowler BS, Jones TS, et al. Campylobacter enteritis at a university: transmission from eating chicken and from cats. Am J Epidemiol. 1987. Sep;126(3):526–34. doi: 10.1093/oxfordjournals.aje.a114685 [DOI] [PubMed] [Google Scholar]
  • 13.Skirrow MB. Campylobacter enteritis: a ‘new’ disease. Br Med J. 1977. Jul 2;2(6078):9–11. doi: 10.1136/bmj.2.6078.9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Butzler JP. Campylobacter, from obscurity to celebrity. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2004. Oct;10(10):868–76. doi: 10.1111/j.1469-0691.2004.00983.x [DOI] [PubMed] [Google Scholar]
  • 15.Wijdicks EFM, Klein CJ. Guillain-Barré Syndrome. Mayo Clin Proc. 2017. Mar;92(3):467–79. [DOI] [PubMed] [Google Scholar]
  • 16.Koga M, Kishi M, Fukusako T, Ikuta N, Kato M, Kanda T. Antecedent infections in Fisher syndrome: sources of variation in clinical characteristics. J Neurol. 2019;266(7):1655–62. doi: 10.1007/s00415-019-09308-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Phongsisay V. The immunobiology of Campylobacter jejuni: Innate immunity and autoimmune diseases. Immunobiology. 2016. Apr;221(4):535–43. doi: 10.1016/j.imbio.2015.12.005 [DOI] [PubMed] [Google Scholar]
  • 18.Goodfellow JA, Willison HJ. Guillain-Barré syndrome: a century of progress. Nat Rev Neurol. 2016. Dec;12(12):723–31. [DOI] [PubMed] [Google Scholar]
  • 19.Yoshida F, Yoshinaka H, Tanaka H, Hanashima S, Yamaguchi Y, Ishihara M, et al. Synthesis of the Core Oligosaccharides of Lipooligosaccharides from Campylobacter jejuni: A Putative Cause of Guillain–Barré Syndrome. Chem–Eur J. 2019;25(3):796–805. [DOI] [PubMed] [Google Scholar]
  • 20.Young KT, Davis LM, Dirita VJ. Campylobacter jejuni: molecular biology and pathogenesis. Nat Rev Microbiol. 2007. Sep;5(9):665–79. doi: 10.1038/nrmicro1718 [DOI] [PubMed] [Google Scholar]
  • 21.Iovine NM. Resistance mechanisms in Campylobacter jejuni. Virulence. 2013. Apr 1;4(3):230–40. doi: 10.4161/viru.23753 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Yang Y, Feye KM, Shi Z, Pavlidis HO, Kogut M, J. Ashworth A, et al. A Historical Review on Antibiotic Resistance of Foodborne Campylobacter. Front Microbiol. 2019;10:1509. doi: 10.3389/fmicb.2019.01509 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, et al. Practice Guidelines for the Management of Infectious Diarrhea. Clin Infect Dis. 2001. Feb 1;32(3):331–51. doi: 10.1086/318514 [DOI] [PubMed] [Google Scholar]
  • 24.Gupta A, Nelson JM, Barrett TJ, Tauxe RV, Rossiter SP, Friedman CR, et al. Antimicrobial Resistance among Campylobacter Strains, United States, 1997–2001. Emerg Infect Dis. 2004. Jun;10(6):1102–9. doi: 10.3201/eid1006.030635 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Endtz HPh, Ruijs GJ, van Klingeren B, Jansen WH, van der Reyden T, Mouton RP. Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J Antimicrob Chemother. 1991. Feb 1;27(2):199–208. doi: 10.1093/jac/27.2.199 [DOI] [PubMed] [Google Scholar]
  • 26.Smith KE, Besser JM, Hedberg CW, Leano FT, Bender JB, Wicklund JH, et al. Quinolone-Resistant Campylobacter jejuni Infections in Minnesota, 1992–1998. N Engl J Med. 1999. May 20;340(20):1525–32. [DOI] [PubMed] [Google Scholar]
  • 27.Lin J, Sahin O, Michel LO, Zhang Q. Critical Role of Multidrug Efflux Pump CmeABC in Bile Resistance and In Vivo Colonization of Campylobacter jejuni. Infect Immun. 2003. Aug 1;71(8):4250–9. doi: 10.1128/IAI.71.8.4250-4259.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Koronakis V, Sharff A, Koronakis E, Luisi B, Hughes C. Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature. 2000. Jun;405(6789):914–9. doi: 10.1038/35016007 [DOI] [PubMed] [Google Scholar]
  • 29.Kulathila R, Kulathila R, Indic M, Berg B van den. Crystal Structure of Escherichia coli CusC, the Outer Membrane Component of a Heavy Metal Efflux Pump. PLOS ONE. 2011. Jan 7;6(1):e15610. doi: 10.1371/journal.pone.0015610 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Lei HT, Chou TH, Su CC, Bolla JR, Kumar N, Radhakrishnan A, et al. Crystal Structure of the Open State of the Neisseria gonorrhoeae MtrE Outer Membrane Channel. PLOS ONE. 2014. Jun 5;9(6):e97475. doi: 10.1371/journal.pone.0097475 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Akama H, Kanemaki M, Yoshimura M, Tsukihara T, Kashiwagi T, Yoneyama H, et al. Crystal Structure of the Drug Discharge Outer Membrane Protein, OprM, of Pseudomonas aeruginosa. J Biol Chem. 2004. Dec 17;279(51):52816–9. [DOI] [PubMed] [Google Scholar]
  • 32.Su CC, Radhakrishnan A, Kumar N, Long F, Bolla JR, Lei HT, et al. Crystal structure of the Campylobacter jejuni CmeC outer membrane channel. Protein Sci. 2014;23(7):954–61. doi: 10.1002/pro.2478 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Young NM, Brisson JR, Kelly J, Watson DC, Tessier L, Lanthier PH, et al. Structure of the N-linked glycan present on multiple glycoproteins in the Gram-negative bacterium, Campylobacter jejuni. J Biol Chem. 2002. Nov 8;277(45):42530–9. doi: 10.1074/jbc.M206114200 [DOI] [PubMed] [Google Scholar]
  • 34.Abouelhadid S, Raynes J, Bui T, Cuccui J, Wren BW. Characterization of Posttranslationally Modified Multidrug Efflux Pumps Reveals an Unexpected Link between Glycosylation and Antimicrobial Resistance. mBio. 2020. Nov 17;11(6):e02604–20. doi: 10.1128/mBio.02604-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Cain JA, Dale AL, Niewold P, Klare WP, Man L, White MY, et al. Proteomics Reveals Multiple Phenotypes Associated with N-linked Glycosylation in Campylobacter jejuni. Mol Cell Proteomics MCP. 2019. Apr;18(4):715–34. doi: 10.1074/mcp.RA118.001199 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Zamora CY, Ward EM, Kester JC, Chen WLK, Velazquez JG, Griffith LG, et al. Application of a gut-immune co-culture system for the study of N-glycan-dependent host-pathogen interactions of Campylobacter jejuni. Glycobiology. 2020. May 19;30(6):374–81. doi: 10.1093/glycob/cwz105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Schulz R, Kleinekathöfer U. Transitions between Closed and Open Conformations of TolC: The Effects of Ions in Simulations. Biophys J. 2009. Apr 22;96(8):3116–25. doi: 10.1016/j.bpj.2009.01.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Vaccaro L, Scott KA, Sansom MSP. Gating at Both Ends and Breathing in the Middle: Conformational Dynamics of TolC. Biophys J. 2008. Dec 15;95(12):5681–91. doi: 10.1529/biophysj.108.136028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Andersen C, Koronakis E, Bokma E, Eswaran J, Humphreys D, Hughes C, et al. Transition to the open state of the TolC periplasmic tunnel entrance. Proc Natl Acad Sci. 2002. Aug 20;99(17):11103–8. doi: 10.1073/pnas.162039399 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Pattanayak BS, Dehury B, Priyadarshinee M, Jha S, Beuria TK, Soren D, et al. Kanamycin-Mediated Conformational Dynamics of Escherichia coli Outer Membrane Protein TolC. Front Mol Biosci. 2021. doi: 10.3389/fmolb.2021.636286 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Raunest M, Kandt C. Locked on One Side Only: Ground State Dynamics of the Outer Membrane Efflux Duct TolC. Biochemistry. 2012. Feb 28;51(8):1719–29. doi: 10.1021/bi201814s [DOI] [PubMed] [Google Scholar]
  • 42.Wang B, Weng J, Wang W. Free energy profiles of ion permeation and doxorubicin translocation in TolC. J Theor Comput Chem. 2014. Jun 1;13(04):1450031. [Google Scholar]
  • 43.Wang B, Weng J, Wang W. Multiple conformational states and gate opening of outer membrane protein TolC revealed by molecular dynamics simulations. Proteins Struct Funct Bioinforma. 2014;82(9):2169–79. doi: 10.1002/prot.24573 [DOI] [PubMed] [Google Scholar]
  • 44.Weng J, Wang W. Structural Features and Energetics of the Periplasmic Entrance Opening of the Outer Membrane Channel TolC Revealed by Molecular Dynamics Simulation and Markov State Model Analysis. J Chem Inf Model. 2019. May 28;59(5):2359–66. doi: 10.1021/acs.jcim.8b00957 [DOI] [PubMed] [Google Scholar]
  • 45.Koch DC, Raunest M, Harder T, Kandt C. Unilateral Access Regulation: Ground State Dynamics of the Pseudomonas aeruginosa Outer Membrane Efflux Duct OprM. Biochemistry. 2013. Jan 8;52(1):178–87. [DOI] [PubMed] [Google Scholar]
  • 46.López CA, Zgurskaya H, Gnanakaran S. Molecular characterization of the outer membrane of Pseudomonas aeruginosa. Biochim Biophys Acta BBA—Biomembr. 2020. Mar 1;1862(3):183151. doi: 10.1016/j.bbamem.2019.183151 [DOI] [PubMed] [Google Scholar]
  • 47.Tamburrino G, Llabrés S, Vickery ON, Pitt SJ, Zachariae U. Modulation of the Neisseria gonorrhoeae drug efflux conduit MtrE. Sci Rep. 2017. Dec 6;7(1):17091. doi: 10.1038/s41598-017-16995-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Arunmanee W, Pathania M, Solovyova AS, Le Brun AP, Ridley H, Baslé A, et al. Gram-negative trimeric porins have specific LPS binding sites that are essential for porin biogenesis. Proc Natl Acad Sci. 2016. Aug 23;113(34):E5034–43. doi: 10.1073/pnas.1602382113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Samsudin F, Khalid S. Movement of Arginine through OprD: The Energetics of Permeation and the Role of Lipopolysaccharide in Directing Arginine to the Protein. J Phys Chem B. 2019. Apr 4;123(13):2824–32. doi: 10.1021/acs.jpcb.9b00063 [DOI] [PubMed] [Google Scholar]
  • 50.Piggot TJ, Holdbrook DA, Khalid S. Conformational dynamics and membrane interactions of the E. coli outer membrane protein FecA: A molecular dynamics simulation study. Biochim Biophys Acta BBA—Biomembr. 2013. Feb 1;1828(2):284–93. [DOI] [PubMed] [Google Scholar]
  • 51.Lee J, Patel DS, Kucharska I, Tamm LK, Im W. Refinement of OprH-LPS Interactions by Molecular Simulations. Biophys J. 2017. Jan 24;112(2):346–55. doi: 10.1016/j.bpj.2016.12.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Kucharska I, Liang B, Ursini N, Tamm LK. Molecular Interactions of Lipopolysaccharide with an Outer Membrane Protein from Pseudomonas aeruginosa Probed by Solution NMR. Biochemistry. 2016. Sep 13;55(36):5061–72. doi: 10.1021/acs.biochem.6b00630 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Gumbart JC, Ferreira JL, Hwang H, Hazel AJ, Cooper CJ, Parks JM, et al. Lpp positions peptidoglycan at the AcrA-TolC interface in the AcrAB-TolC multidrug efflux pump. Biophys J. 2021. Aug 17 doi: 10.1016/j.bpj.2021.08.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Leach S, Harvey P, Wait R. Changes with growth rate in the membrane lipid composition of and amino acid utilization by continuous cultures of Campylobacter jejuni. J Appl Microbiol. 1997;82(5):631–40. doi: 10.1111/j.1365-2672.1997.tb02873.x [DOI] [PubMed] [Google Scholar]
  • 55.Lee J, Patel DS, Ståhle J, Park SJ, Kern NR, Kim S, et al. CHARMM-GUI Membrane Builder for Complex Biological Membrane Simulations with Glycolipids and Lipoglycans. J Chem Theory Comput. 2019. Jan 8;15(1):775–86. [DOI] [PubMed] [Google Scholar]
  • 56.Cao X, Brouwers JFHM, van Dijk L, van de Lest CHA, Parker CT, Huynh S, et al. The Unique Phospholipidome of the Enteric Pathogen Campylobacter jejuni: Lysophosholipids Are Required for Motility at Low Oxygen Availability. J Mol Biol. 2020. Sep 4;432(19):5244–58. doi: 10.1016/j.jmb.2020.07.012 [DOI] [PubMed] [Google Scholar]
  • 57.Hsu PC, Samsudin F, Shearer J, Khalid S. It Is Complicated: Curvature, Diffusion, and Lipid Sorting within the Two Membranes of Escherichia coli. J Phys Chem Lett. 2017. Nov 16;8(22):5513–8. doi: 10.1021/acs.jpclett.7b02432 [DOI] [PubMed] [Google Scholar]
  • 58.Lee HS, Qi Y, Im W. Effects of N-glycosylation on protein conformation and dynamics: Protein Data Bank analysis and molecular dynamics simulation study. Sci Rep. 2015. Mar 9;5(1):8926. doi: 10.1038/srep08926 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Slynko V, Schubert M, Numao S, Kowarik M, Aebi M, Allain FHT. NMR Structure Determination of a Segmentally Labeled Glycoprotein Using in Vitro Glycosylation. J Am Chem Soc. 2009. Jan 28;131(3):1274–81. doi: 10.1021/ja808682v [DOI] [PubMed] [Google Scholar]
  • 60.Pedebos C, Arantes PR, Giesel GM, Verli H. In silico Investigation of the PglB Active Site Reveals Transient Catalytic States and Octahedral Metal Ion Coordination. Glycobiology. 2015. Nov 1;25(11):1183–95. doi: 10.1093/glycob/cwv053 [DOI] [PubMed] [Google Scholar]
  • 61.Phan G, Benabdelhak H, Lascombe MB, Benas P, Rety S, Picard M, et al. Structural and Dynamical Insights into the Opening Mechanism of P. aeruginosa OprM Channel. Structure. 2010. Mar 14;18(4):507–17. doi: 10.1016/j.str.2010.01.018 [DOI] [PubMed] [Google Scholar]
  • 62.Zhang Z, Ryoo D, Balusek C, Acharya A, Rydmark MO, Linke D, et al. Inward-facing glycine residues create sharp turns in β-barrel membrane proteins. Biochim Biophys Acta BBA—Biomembr. 2021. Oct 1;1863(10):183662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Smart OS, Neduvelil JG, Wang X, Wallace BA, Sansom MSP. HOLE: A program for the analysis of the pore dimensions of ion channel structural models. J Mol Graph. 1996. Dec 1;14(6):354–60. doi: 10.1016/s0263-7855(97)00009-x [DOI] [PubMed] [Google Scholar]
  • 64.Chen M, Shi X, Yu Z, Fan G, Serysheva II, Baker ML, et al. In situ structure of the AcrAB-TolC efflux pump at subnanometer resolution. Structure. 2022. Jan 6;30(1):107–113.e3. doi: 10.1016/j.str.2021.08.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Shi X, Chen M, Yu Z, Bell JM, Wang H, Forrester I, et al. In situ structure and assembly of the multidrug efflux pump AcrAB-TolC. Nat Commun. 2019. Jun 14;10(1):2635. doi: 10.1038/s41467-019-10512-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Akiba M, Lin J, Barton YW, Zhang Q. Interaction of CmeABC and CmeDEF in conferring antimicrobial resistance and maintaining cell viability in Campylobacter jejuni. J Antimicrob Chemother. 2006. Jan 1;57(1):52–60. doi: 10.1093/jac/dki419 [DOI] [PubMed] [Google Scholar]
  • 67.Masi M, Saint N, Molle G, Pagès JM. The Enterobacter aerogenes outer membrane efflux proteins TolC and EefC have different channel properties. Biochim Biophys Acta BBA—Biomembr. 2007. Oct 1;1768(10):2559–67. doi: 10.1016/j.bbamem.2007.06.008 [DOI] [PubMed] [Google Scholar]
  • 68.Andersen C, Koronakis E, Hughes C, Koronakis V. An aspartate ring at the TolC tunnel entrance determines ion selectivity and presents a target for blocking by large cations. Mol Microbiol. 2002;44(5):1131–9. doi: 10.1046/j.1365-2958.2002.02898.x [DOI] [PubMed] [Google Scholar]
  • 69.Gilardi A, Bhamidimarri SP, Brönstrup M, Bilitewski U, Marreddy RKR, Pos KM, et al. Biophysical characterization of E. coli TolC interaction with the known blocker hexaamminecobalt. Biochim Biophys Acta BBA—Gen Subj. 2017. Nov 1;1861(11, Part A):2702–9. doi: 10.1016/j.bbagen.2017.07.014 [DOI] [PubMed] [Google Scholar]
  • 70.Higgins MK, Eswaran J, Edwards P, Schertler GFX, Hughes C, Koronakis V. Structure of the Ligand-blocked Periplasmic Entrance of the Bacterial Multidrug Efflux Protein TolC. J Mol Biol. 2004. Sep 17;342(3):697–702. doi: 10.1016/j.jmb.2004.07.088 [DOI] [PubMed] [Google Scholar]
  • 71.Kastowsky M, Sabisch A, Gutberlet T, Bradaczek H. Molecular modelling of bacterial deep rough mutant lipopolysaccharide of Escherichia coli. Eur J Biochem. 1991;197(3):707–16. doi: 10.1111/j.1432-1033.1991.tb15962.x [DOI] [PubMed] [Google Scholar]
  • 72.Clifton LA, Skoda MWA, Le Brun AP, Ciesielski F, Kuzmenko I, Holt SA, et al. Effect of Divalent Cation Removal on the Structure of Gram-Negative Bacterial Outer Membrane Models. Langmuir. 2015. Jan 13;31(1):404–12. doi: 10.1021/la504407v [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Raetz CRH, Reynolds CM, Trent MS, Bishop RE. Lipid A Modification Systems in Gram-Negative Bacteria. Annu Rev Biochem. 2007;76(1):295–329. doi: 10.1146/annurev.biochem.76.010307.145803 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Oliveira RG, Schneck E, Quinn BE, Konovalov OV, Brandenburg K, Gutsmann T, et al. Crucial roles of charged saccharide moieties in survival of gram negative bacteria against protamine revealed by combination of grazing incidence x-ray structural characterizations and Monte Carlo simulations. Phys Rev E. 2010. Apr 2;81(4):041901. doi: 10.1103/PhysRevE.81.041901 [DOI] [PubMed] [Google Scholar]
  • 75.Murata T, Tseng W, Guina T, Miller SI, Nikaido H. PhoPQ-Mediated Regulation Produces a More Robust Permeability Barrier in the Outer Membrane of Salmonella enterica Serovar Typhimurium. J Bacteriol. 2007. Oct 15;189(20):7213–22. doi: 10.1128/JB.00973-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Jefferies D, Hsu PC, Khalid S. Through the Lipopolysaccharide Glass: A Potent Antimicrobial Peptide Induces Phase Changes in Membranes. Biochemistry. 2017. Mar 21;56(11):1672–9. doi: 10.1021/acs.biochem.6b01063 [DOI] [PubMed] [Google Scholar]
  • 77.Nascimento A, Pontes FJS, Lins RD, Soares TA. Hydration, ionic valence and cross-linking propensities of cations determine the stability of lipopolysaccharide (LPS) membranes. Chem Commun. 2013. Nov 28;50(2):231–3. [DOI] [PubMed] [Google Scholar]
  • 78.Pontes FJS, Rusu VH, Soares TA, Lins RD. The Effect of Temperature, Cations, and Number of Acyl Chains on the Lamellar to Non-Lamellar Transition in Lipid-A Membranes: A Microscopic View. J Chem Theory Comput. 2012. Oct 9;8(10):3830–8. doi: 10.1021/ct300084v [DOI] [PubMed] [Google Scholar]
  • 79.Santos DES, Pol-Fachin L, Lins RD, Soares TA. Polymyxin Binding to the Bacterial Outer Membrane Reveals Cation Displacement and Increasing Membrane Curvature in Susceptible but Not in Resistant Lipopolysaccharide Chemotypes. J Chem Inf Model. 2017. Sep 25;57(9):2181–93. doi: 10.1021/acs.jcim.7b00271 [DOI] [PubMed] [Google Scholar]
  • 80.Kesireddy A, Pothula KR, Lee J, Patel DS, Pathania M, van den Berg B, et al. Modeling of Specific Lipopolysaccharide Binding Sites on a Gram-Negative Porin. J Phys Chem B. 2019. Jul 11;123(27):5700–8. doi: 10.1021/acs.jpcb.9b03669 [DOI] [PubMed] [Google Scholar]
  • 81.Clifton LA, Holt SA, Hughes AV, Daulton EL, Arunmanee W, Heinrich F, et al. An Accurate In Vitro Model of the E. coli Envelope. Angew Chem Int Ed. 2015;54(41):11952–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Zhang A, Yu H, Liu C, Song C. The Ca2+ permeation mechanism of the ryanodine receptor revealed by a multi-site ion model. Nat Commun. 2020. Feb 17;11(1):922. doi: 10.1038/s41467-020-14573-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Li H, Ngo V, Da Silva MC, Salahub DR, Callahan K, Roux B, et al. Representation of Ion–Protein Interactions Using the Drude Polarizable Force-Field. J Phys Chem B. 2015. Jul 23;119(29):9401–16. doi: 10.1021/jp510560k [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Newest CHARMM36 port for GROMACS—Third party tools and files [Internet]. GROMACS forums. 2020 [cited 2022 Oct 20]. Available from: https://gromacs.bioexcel.eu/t/newest-charmm36-port-for-gromacs/868
  • 85.Liu H, Fu H, Chipot C, Shao X, Cai W. Accuracy of Alternate Nonpolarizable Force Fields for the Determination of Protein–Ligand Binding Affinities Dominated by Cation−π Interactions. J Chem Theory Comput. 2021. Jul 13;17(7):3908–15. [DOI] [PubMed] [Google Scholar]
  • 86.Jalilehvand F, Spångberg D, Lindqvist-Reis P, Hermansson K, Persson I, Sandström M. Hydration of the Calcium Ion. An EXAFS, Large-Angle X-ray Scattering, and Molecular Dynamics Simulation Study. J Am Chem Soc. 2001. Jan 1;123(3):431–41. doi: 10.1021/ja001533a [DOI] [PubMed] [Google Scholar]
  • 87.Luo N, Sahin O, Lin J, Michel LO, Zhang Q. In Vivo Selection of Campylobacter Isolates with High Levels of Fluoroquinolone Resistance Associated with gyrA Mutations and the Function of the CmeABC Efflux Pump. Antimicrob Agents Chemother. 2003. Jan;47(1):390–4. doi: 10.1128/AAC.47.1.390-394.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Gibreel A, Wetsch NM, Taylor DE. Contribution of the CmeABC Efflux Pump to Macrolide and Tetracycline Resistance in Campylobacter jejuni. Antimicrob Agents Chemother. 2007. Sep;51(9):3212–6. doi: 10.1128/AAC.01592-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Lin J, Overbye Michel L, Zhang Q. CmeABC Functions as a Multidrug Efflux System in Campylobacter jejuni. Antimicrob Agents Chemother. 2002. Jul;46(7):2124–31. doi: 10.1128/AAC.46.7.2124-2131.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Martinez A, Lin J. Effect of an efflux pump inhibitor on the function of the multidrug efflux pump CmeABC and antimicrobial resistance in Campylobacter. Foodborne Pathog Dis. 2006;3(4):393–402. doi: 10.1089/fpd.2006.3.393 [DOI] [PubMed] [Google Scholar]
  • 91.Salazar-Lindo E, Sack RB, Chea-Woo E, Kay BA, Piscoya ZA, Leon-Barua R, et al. Early treatment with erythromycin of Campylobacter jejuni-associated dysentery in children. J Pediatr. 1986. Aug;109(2):355–60. doi: 10.1016/s0022-3476(86)80404-8 [DOI] [PubMed] [Google Scholar]
  • 92.Hofmann AF, Hagey LR, Krasowski MD. Bile salts of vertebrates: structural variation and possible evolutionary significance. J Lipid Res. 2010. Feb;51(2):226–46. doi: 10.1194/jlr.R000042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Parkin J, Khalid S. Atomistic molecular-dynamics simulations enable prediction of the arginine permeation pathway through OccD1/OprD from Pseudomonas aeruginosa. Biophys J. 2014. Oct 21;107(8):1853–61. doi: 10.1016/j.bpj.2014.08.035 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Jarzynski C. Nonequilibrium Equality for Free Energy Differences. Phys Rev Lett. 1997. Apr 7;78(14):2690–3. [Google Scholar]
  • 95.Cohen EGD, Mauzerall D. A note on the Jarzynski equality. J Stat Mech Theory Exp. 2004. Jul;2004(07):P07006. [Google Scholar]
  • 96.Baştuğ T, Kuyucak S. Application of Jarzynski’s equality in simple versus complex systems. Chem Phys Lett. 2007. Mar 9;436(4):383–7. [Google Scholar]
  • 97.Kuang Z, Singh KM, Oliver DJ, Dennis PB, Perry CC, Naik RR. Gamma estimator of Jarzynski equality for recovering binding energies from noisy dynamic data sets. Nat Commun. 2020. Nov 2;11(1):5517. doi: 10.1038/s41467-020-19233-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Huang J, MacKerell AD. CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data. J Comput Chem. 2013. Sep 30;34(25):2135–45. doi: 10.1002/jcc.23354 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Huang J, Rauscher S, Nawrocki G, Ran T, Feig M, de Groot BL, et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat Methods. 2017. Jan;14(1):71–3. doi: 10.1038/nmeth.4067 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983. Jul 15;79(2):926–35. [Google Scholar]
  • 101.Berendsen HJC, van der Spoel D, van Drunen R. GROMACS: A message-passing parallel molecular dynamics implementation. Comput Phys Commun. 1995. Sep 2;91(1):43–56. [Google Scholar]
  • 102.Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJC. GROMACS: Fast, flexible, and free. J Comput Chem. 2005;26(16):1701–18. doi: 10.1002/jcc.20291 [DOI] [PubMed] [Google Scholar]
  • 103.Hess B, Bekker H, Berendsen HJC, Fraaije JGEM. LINCS: A linear constraint solver for molecular simulations. J Comput Chem. 1997;18(12):1463–72. [Google Scholar]
  • 104.Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG. A smooth particle mesh Ewald method. J Chem Phys. 1995. Nov 15;103(19):8577–93. [Google Scholar]
  • 105.Bussi G, Donadio D, Parrinello M. Canonical sampling through velocity rescaling. J Chem Phys. 2007. Jan 7;126(1):014101. doi: 10.1063/1.2408420 [DOI] [PubMed] [Google Scholar]
  • 106.Harris CR, Millman KJ, van der Walt SJ, Gommers R, Virtanen P, Cournapeau D, et al. Array programming with NumPy. Nature. 2020. Sep;585(7825):357–62. doi: 10.1038/s41586-020-2649-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.McKinney W. pandas: a Foundational Python Library for Data Analysis and Statistics. 2011;9. [Google Scholar]
  • 108.Gowers R, Linke M, Barnoud J, Reddy T, Melo M, Seyler S, et al. MDAnalysis: A Python Package for the Rapid Analysis of Molecular Dynamics Simulations. In Austin, Texas; 2016. p. 98–105. [Google Scholar]
  • 109.Michaud-Agrawal N, Denning EJ, Woolf TB, Beckstein O. MDAnalysis: A toolkit for the analysis of molecular dynamics simulations. J Comput Chem. 2011;32(10):2319–27. doi: 10.1002/jcc.21787 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Humphrey W, Dalke A, Schulten K. VMD: Visual molecular dynamics. J Mol Graph. 1996. Feb 1;14(1):33–8. doi: 10.1016/0263-7855(96)00018-5 [DOI] [PubMed] [Google Scholar]
  • 111.Webb B, Sali A. Comparative Protein Structure Modeling Using MODELLER. Curr Protoc Bioinforma. 2016. Jun 20;54:5.6.1–5.6.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112.Jo S, Kim T, Iyer VG, Im W. CHARMM-GUI: A web-based graphical user interface for CHARMM. J Comput Chem. 2008;29(11):1859–65. doi: 10.1002/jcc.20945 [DOI] [PubMed] [Google Scholar]
  • 113.Goldstein AA. On Steepest Descent. J Soc Ind Appl Math Ser Control. 1965. Jan 1;3(1):147–51. [Google Scholar]
  • 114.Berendsen HJC, Postma JPM, van Gunsteren WF, DiNola A, Haak JR. Molecular dynamics with coupling to an external bath. J Chem Phys. 1984. Oct 15;81(8):3684–90. [Google Scholar]
  • 115.Parrinello M, Rahman A. Polymorphic transitions in single crystals: A new molecular dynamics method. J Appl Phys. 1981. Dec 1;52(12):7182–90. [Google Scholar]
  • 116.Nosé S, Klein ML. A molecular dynamics method for simulations in the canonical ensemble. Mol Phys. 1984. Jun 10;52(2):255–68. [Google Scholar]
  • 117.Kim S, Lee J, Jo S, Brooks CL III, Lee HS, Im W. CHARMM-GUI ligand reader and modeler for CHARMM force field generation of small molecules. J Comput Chem. 2017;38(21):1879–86. doi: 10.1002/jcc.24829 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Prentice JCA, Aarons J, Womack JC, Allen AEA, Andrinopoulos L, Anton L, et al. The ONETEP linear-scaling density functional theory program. J Chem Phys. 2020. May 7;152(17):174111. doi: 10.1063/5.0004445 [DOI] [PubMed] [Google Scholar]
  • 119.Skylaris CK, Haynes PD, Mostofi AA, Payne MC. Introducing ONETEP: Linear-scaling density functional simulations on parallel computers. J Chem Phys. 2005. Feb 22;122(8):084119. doi: 10.1063/1.1839852 [DOI] [PubMed] [Google Scholar]
  • 120.Perdew JP, Burke K, Ernzerhof M. Generalized Gradient Approximation Made Simple. Phys Rev Lett. 1996. Oct 28;77(18):3865–8. doi: 10.1103/PhysRevLett.77.3865 [DOI] [PubMed] [Google Scholar]
  • 121.Grimme S. Semiempirical GGA-type density functional constructed with a long-range dispersion correction. J Comput Chem. 2006;27(15):1787–99. doi: 10.1002/jcc.20495 [DOI] [PubMed] [Google Scholar]
PLoS Comput Biol. doi: 10.1371/journal.pcbi.1010841.r001

Decision Letter 0

Nir Ben-Tal, Guanghong Wei

19 Oct 2022

Dear Professor KHALID,

Thank you very much for submitting your manuscript "Conformational dynamics and putative substrate extrusion pathways of the N-glycosylated outer membrane factor CmeC from Campylobacter jejuni" for consideration at PLOS Computational Biology. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by three independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Guanghong Wei

Academic Editor

PLOS Computational Biology

Nir Ben-Tal

Section Editor

PLOS Computational Biology

***********************

A link appears below if there are any accompanying review attachments. If you believe any reviews to be missing, please contact ploscompbiol@plos.org immediately:

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: In this manuscript, the authors conducted extensive molecular dynamics simulations to investigate the conformational dynamics of a N-glycosylated outer membrane factor CmeC and the possible extrusion pathway of small ligands which can be exported from the intracellular side to the extracellular side of the bilayer by this protein. The OMF is responsible for antibiotic resistance of the bacteria, Campylobacter jejuni, and therefore studying its mechanism of exporting small ligands is of interest to the community. The authors described in detail the conformation of the protein in equilibrium simulations, as well as how the saccharides affected its conformation. The authors also employed non-equilibrium simulations to pull two ligands across the channel. The authors concluded the manuscript with possible gates of the channel and a probably mechanism for negatively charged ligands using cations to climb a channel whose inner surface is full of acid residues.

Overall, the technique used in this work is solid, the results were analyzed properly and the manuscript was written in reasonable quality. I only have some minor issues which the authors may want to consider before the publication of this manuscript:

1, The authors used both potassium ions and calcium ions in their system. However, in their work, they mentioned that they found little potassium density inside the channel, but notable calcium density. What would be the possible reason for this difference? Is this a possible artifact of the used force field (as far as I know, the current ff with fixed charges are not perfect to describe ions, particularly multivalent cations), or there was some more fundamental reason? This should be discussed in the manuscript.

Also, the authors said that, they used calcium ions to neutralize the negatively charged LOS lipids. Why this particular cation is necessary for this purpose? Please clarify.

2, On the one hand, the authors mentioned that they identified higher calcium density than the potassium density inside the channel, on the other hand, the authors said that removing the calcium only increased the TCA slightly, while removing the both types of ions increased the TCA significantly. The reason should be explained. Why minor potassium had more dramatic effects than the more enriched calcium?

Probably a comparison of the distribution of two different ions in the channel would be helpful: this distribution will show if the potassium is really not distributed in the channel or if they are just not coordinate stably with the acid residues.

3, The authors performed principal component analyses in their work. The three simulation replicates showed complete different conformational space according to the principal components, what does this mean actually? It doesn’t seem to be a result of insufficient sampling.

Also, how the PCA analyses were conducted is not clear. Did the authors conducted PCA for each trajectory separately, or they combined all of the trajectories and then conducted PCA for the combined frames all together? If the former, did the corresponding principal components from three trajectories indicate the same collective motions? Please clarify.

The authors said the conformational space of three trajectories are unique from the crystal structure, but the PCs of the crystal structure was not labeled in Fig. 2. Besides, how much percentage did the first three PCs account for among all of the PCs (in another word, was it enough to only look at the first three PCs)?

4, the authors mentioned the two constriction regions at the periplasmic entrance and the extracellular exit in the introduction section, however, it is not clear where these regions are in Fig. 1. Of course, the positions were elaborated later in the manuscript, but I would suggest also label them in Fig. 1.

5, CDCA was supposed to utilize cations to climb the acid residue ladders of the channel, and this process was supposed to increase the ratio of the frames in which calcium ions were coordinated by acid residues. From Table 1, we can see that coordination of calcium by D77 was increased more significantly than the other residues, why this residue is so special? Please explain. For other residues, the increase was between 3%-10% (except for D86), did this minor difference has statistical significance?

6, the authors presented the orientation of the ligands in the channel by showing these ligands from different frames in one figure. However, I am afraid this might not be a perfect way to describe the ligand orientations. I suggest the authors to define other ways, such as define vectors and angles/dihedrals or show densities of specific atoms.

7, please clarify the concentration of calcium ions used in the work. The concentration of KCL was mentioned but not for the calcium ions.

Reviewer #2: This manuscript nicely describes the influence of structure and function for CmeC by lipid membrane models, ions, efflux of drugs. There is an extensive set of simulations that albeit not fully equilibrated provide some details on structural influences on CmeC by various conditions. Although I find this manuscript publishable, my comments and suggestions below should be addressed.

General Comments:

1. Outer membrane (OM) mimic: It is nice to see that the simulations utilize a mimic for the outer membrane with LOS, which better represents the natural environment for CmeC. However, the membrane model used is a mimic and not representative of the natural OM of C. jejuni. The authors should make this clear in the main document.

2. Equilibration (lack of): The authors are very clear and open about their research and that the protein is still changing in structure. It would be nice to provide a bit more detail on what regions of the protein are still changing. Moreover, does this relate to the crystal structure conditions vs. the more natural conditions simulated in this work? Some more physical insight into the inability to stabilize the structure would be good.

Reviewer #3: The manuscript entitled 'Conformational dynamics and putative substrate extrusion pathways of the N- glycosylated outer membrane factor CmeC from Campylobacter jejuni' by authors Kahlan Newman and Syma Khalid is an interesting study of the dynamics of a previously not dynamically investigated RND efflux pump outer duct. The work is technically sound in general, very well written, and provides interesting insights on the dynamics of loops, N-glycans and the trimer as a whole. Of particular interest is the role of the inner pore lining, which is especially rich in acidic side chains. The authors ought to be commended for using realistic outer membrane models and post-translational modification. I only have a few questions:

* The default model for calcium ion is known to overestimate protein-ion affinity (see for example doi: 10.1038/s41467-020-14573-w). The density and position of calcium ions near the protein is quite important for the results of this work - can the authors please comment why they chose the default model and discuss any possible implications for the results?

* I wonder why no attempt was made to estimate the free energy surface for substrate translocation by using the steered MD results along with the Jarzynski equality rather than by umbrella sampling since the steered MD trajectories already exist. Was there poor convergence for instance?

* Ion attraction sites, the electrostatic properties of the gating region, and pore gating in a similar outward efflux duct from Neisseria gonorrhoeae were studied by MD in doi: 10.1038/s41598-017-16995-x ; I think this paper is relevant previous work and the authors may want to discuss it.

* Are any inhibitors of this outward duct known and if so, where do they bind?

**********

Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example in PLOS Biology see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

 

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

References:

Review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript.

If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

PLoS Comput Biol. doi: 10.1371/journal.pcbi.1010841.r003

Decision Letter 1

Nir Ben-Tal, Guanghong Wei

26 Dec 2022

Dear Professor KHALID,

We are pleased to inform you that your manuscript 'Conformational dynamics and putative substrate extrusion pathways of the N-glycosylated outer membrane factor CmeC from Campylobacter jejuni' has been provisionally accepted for publication in PLOS Computational Biology.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Computational Biology. 

Best regards,

Guanghong Wei

Academic Editor

PLOS Computational Biology

Nir Ben-Tal

Section Editor

PLOS Computational Biology

***********************************************************

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: All of my concerns have been addressed, I do not have more suggestions.

Reviewer #2: This revision is acceptable for publication.

Reviewer #3: all points have been addressed in style !

**********

Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: None

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

PLoS Comput Biol. doi: 10.1371/journal.pcbi.1010841.r004

Acceptance letter

Nir Ben-Tal, Guanghong Wei

10 Jan 2023

PCOMPBIOL-D-22-01360R1

Conformational dynamics and putative substrate extrusion pathways of the N-glycosylated outer membrane factor CmeC from Campylobacter jejuni

Dear Dr Khalid,

I am pleased to inform you that your manuscript has been formally accepted for publication in PLOS Computational Biology. Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Computational Biology and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Zsofia Freund

PLOS Computational Biology | Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom ploscompbiol@plos.org | Phone +44 (0) 1223-442824 | ploscompbiol.org | @PLOSCompBiol

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Chemical structure of the heptasaccharide attached to N13 and N30 in CmeC.

    (TIF)

    S2 Fig. Timeseries data of the simulation box dimensions.

    X and Y dimensions of the box are coupled (semi-isotropic pressure coupling used). Box dimensions are stable after ~300 ns.

    (TIF)

    S3 Fig. Top: Root-mean-square deviation (RMSD) of the protein backbone in each replicate.

    In all three replicates the RMSD is still increasing at 500 ns, indicating that CmeC is not yet fully equilibrated. Bottom: When one replicate was extended to 1250 ns, the backbone RMSD continued to increase.

    (TIF)

    S4 Fig. Secondary structure analysis (STRIDE) for CmeC from one replicate across the 500 ns simulation.

    (TIF)

    S5 Fig

    Timeseries data of the angle defined between the protein principal axis (approximately parallel to the z-axis) and the glycan vector (defined in Fig 4E). A wide variety of relative orientations are observed.

    (TIF)

    S6 Fig. Distribution of end-to-end lengths for the heptasaccharide.

    Ther is considerably more variation in this value than would be expected from a ‘rigid-rod’.

    (TIF)

    S7 Fig. Distribution of Ψ and Φ values for each glycosidic linkage in the heptasaccharide.

    Data from our equilibrium simulations plotted in blue. Values defined by the mean ± standard deviation in Ref 60 for each linkage shaded in yellow

    (TIF)

    S8 Fig. Potassium ion density proximal to CmeC.

    A small amount of potassium ion density is located near D86 within the channel.

    (TIF)

    S9 Fig. Comparison of protein backbone RMSD from equilibrium simulations, systems where calcium ions were removed from within CmeC, and systems where both calcium and potassium ions were removed from within CmeC.

    Systems where cations were removed saw increased RMSD values compared to equilibrium simulations, though this is most pronounced in systems where both calcium and potassium ions were removed.

    (TIF)

    S10 Fig. Hydrogen bond count in the coiled-coil region of CmeC (hydrogen bonds between different helices only) for replicate 1 of the system with both calcium and potassium ions removed from within the channel.

    Dashed pink vertical lines indicate times at which there was a peak in TCAE416; there is no clear increase or decrease in the number of these hydrogen bonds (inter- or intraprotomer) correlated with peaks in TCA.

    (TIF)

    S11 Fig. Scatter plots of the force against the hydration shell population at positions within the CmeC channel, with points coloured by the channel radius, demonstrating correlation between the force required for translocation and both the channel radius and the population of the hydration shell.

    (TIF)

    S12 Fig. Occupancy map for a hydroxyl oxygen in Erythromycin (right, highlighted) over the steered MD simulations.

    The occupancy is delocalised in the channel. The only clear localised region of high occupancy is at the periplasmic entrance, where the rotational freedom of erythromycin is limited due to the narrow channel diameter.

    (TIF)

    S13 Fig. Electrostatic profile of erythromycin.

    Colour scale: -1 V in red to +1 V in blue. Electronegative groups are distributed around the erythromycin molecule.

    (TIF)

    S14 Fig. Electrostatic profile of CDCA.

    Colour scale: -1 V in red to +1 V in blue. While there are three electronegative functional groups in CDCA, the carboxylate group dominates.

    (TIF)

    S15 Fig. Occupancy map for a carboylate oxygen in chenodeoxycholic acid (right, highlighted) over the steered MD simulations.

    There are several localised regions of high within the channel. These align with acidic lining residues where CDCA is coordinating a bound protein-bound calcium ion.

    (TIF)

    S1 Table. Percentage variance explained by the first 10 eigenvectors identified via principal component analysis.

    (PDF)

    S2 Table. Mean values of Ψ and Φ for each linkage in the heptasaccharide, with associated standard deviation.

    (PDF)

    Attachment

    Submitted filename: Response_To_Reviewers.docx

    Data Availability Statement

    All input files necessary to run the simulations, and all resulting trajectories discussed in the paper are available on Zenodo: https://doi.org/10.5281/zenodo.7041473.


    Articles from PLOS Computational Biology are provided here courtesy of PLOS

    RESOURCES